,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1375119,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Plant extracts inhibits the reaction [streptozocin results in increased expression of RELA protein],,,PMID:19123331,https://www.ncbi.nlm.nih.gov/pubmed/19123331,19123331,,
1,1375120,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased activity of RELA protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased activity of RELA protein],,,PMID:23406761,https://www.ncbi.nlm.nih.gov/pubmed/23406761,23406761,,
2,1375121,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Streptozocin affects the localization of and results in decreased activity of RELA protein,,,PMID:19002579,https://www.ncbi.nlm.nih.gov/pubmed/19002579,19002579,,
3,1375122,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Streptozocin affects the localization of RELA protein,,,PMID:24740756|PMID:25541178,https://www.ncbi.nlm.nih.gov/pubmed/24740756|https://www.ncbi.nlm.nih.gov/pubmed/25541178,24740756|25541178,,
4,1375123,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with dietary fats] results in increased expression of RELA protein,,,PMID:24877639|PMID:26341651,https://www.ncbi.nlm.nih.gov/pubmed/24877639|https://www.ncbi.nlm.nih.gov/pubmed/26341651,24877639|26341651,,
5,1375124,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Streptozocin results in increased expression of and results in increased phosphorylation of RELA protein|stub1 inhibits the reaction [streptozocin results in increased phosphorylation of RELA protein],,,PMID:35442559,https://www.ncbi.nlm.nih.gov/pubmed/35442559,35442559,,
6,1375723,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10116,Rattus norvegicus (Norway rat),[dietary fats co-treated with streptozocin] results in decreased expression of SCD1 mrna|[dietary fats co-treated with streptozocin co-treated with carbamazepine] results in decreased expression of SCD1 mrna|[dietary fats affects the susceptibility to streptozocin] which results in decreased expression of SCD1 mrna|[[dietary fats co-treated with carbamazepine] affects the susceptibility to streptozocin] which results in decreased expression of SCD1 mrna|[[streptozocin co-treated with carbamazepine] affects the susceptibility to dietary fats] which results in decreased expression of SCD1 mRNA,,,PMID:35786680,https://www.ncbi.nlm.nih.gov/pubmed/35786680,35786680,,
7,1375724,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6389,SDHA,https://ctdbase.org/detail.go?type=gene&acc=6389,,,6389.0,SDHA,10116,Rattus norvegicus (Norway rat),Trientine inhibits the reaction [streptozocin results in increased expression of SDHA protein]|streptozocin results in increased expression of SDHA protein,,,PMID:19634143|PMID:21136691,https://www.ncbi.nlm.nih.gov/pubmed/19634143|https://www.ncbi.nlm.nih.gov/pubmed/21136691,19634143|21136691,,
8,1375725,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6390,SDHB,https://ctdbase.org/detail.go?type=gene&acc=6390,,,6390.0,SDHB,10116,Rattus norvegicus (Norway rat),Streptozocin results in increased expression of SDHB protein|trientine inhibits the reaction [streptozocin results in increased expression of SDHB protein],,,PMID:19634143,https://www.ncbi.nlm.nih.gov/pubmed/19634143,19634143,,
9,1376355,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6507,SLC1A3,https://ctdbase.org/detail.go?type=gene&acc=6507,,,6507.0,SLC1A3,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [streptozocin results in decreased expression of SLC1A3 mrna]|resveratrol inhibits the reaction [streptozocin results in decreased expression of SLC1A3 protein]|streptozocin results in decreased expression of SLC1A3 protein,,,PMID:26677078,https://www.ncbi.nlm.nih.gov/pubmed/26677078,26677078,,
10,1376356,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6507,SLC1A3,https://ctdbase.org/detail.go?type=gene&acc=6507,,,6507.0,SLC1A3,10116,Rattus norvegicus (Norway rat),Streptozocin results in decreased expression of SLC1A3 mRNA,,,PMID:23267840|PMID:26677078,https://www.ncbi.nlm.nih.gov/pubmed/23267840|https://www.ncbi.nlm.nih.gov/pubmed/26677078,23267840|26677078,,
11,1376357,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6575,SLC20A2,https://ctdbase.org/detail.go?type=gene&acc=6575,,,6575.0,SLC20A2,10090,Mus musculus (house mouse),INS1 protein inhibits the reaction [streptozocin results in increased expression of SLC20A2 mrna]|streptozocin results in increased expression of SLC20A2 mrna|ins1 protein inhibits the reaction [streptozocin results in increased expression of SLC20A2 protein]|streptozocin results in increased expression of SLC20A2 protein,,,PMID:29216956,https://www.ncbi.nlm.nih.gov/pubmed/29216956,29216956,,
12,1376358,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6580,SLC22A1,https://ctdbase.org/detail.go?type=gene&acc=6580,,,6580.0,SLC22A1,10116,Rattus norvegicus (Norway rat),Streptozocin results in decreased expression of SLC22A1 protein,,,PMID:19605544,https://www.ncbi.nlm.nih.gov/pubmed/19605544,19605544,,
13,1376359,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582.0,SLC22A2,10116,Rattus norvegicus (Norway rat),Streptozocin results in decreased expression of SLC22A2 protein,,,PMID:19605544,https://www.ncbi.nlm.nih.gov/pubmed/19605544,19605544,,
14,1376360,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,236293,SLC22A29,https://ctdbase.org/detail.go?type=gene&acc=236293,,,236293.0,Slc22a29,10090,Mus musculus (house mouse),[streptozocin co-treated with dietary fats co-treated with diethylhexyl phthalate] results in increased expression of SLC22A29 mRNA,,,PMID:33484791,https://www.ncbi.nlm.nih.gov/pubmed/33484791,33484791,,
15,1376361,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,9356,SLC22A6,https://ctdbase.org/detail.go?type=gene&acc=9356,,,9356.0,SLC22A6,10116,Rattus norvegicus (Norway rat),Streptozocin results in decreased expression of SLC22A6 protein|trientine inhibits the reaction [streptozocin results in decreased expression of SLC22A6 protein],,,PMID:19634143,https://www.ncbi.nlm.nih.gov/pubmed/19634143,19634143,,
16,1376362,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6576,SLC25A1,https://ctdbase.org/detail.go?type=gene&acc=6576,,,6576.0,SLC25A1,10116,Rattus norvegicus (Norway rat),Cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A1 protein]|streptozocin results in decreased expression of SLC25A1 protein|tin mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A1 protein]],,,PMID:16595661,https://www.ncbi.nlm.nih.gov/pubmed/16595661,16595661,,
17,1376473,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,1468,SLC25A10,https://ctdbase.org/detail.go?type=gene&acc=1468,,,1468.0,SLC25A10,10116,Rattus norvegicus (Norway rat),Streptozocin results in decreased expression of SLC25A10 protein|tin mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A10 protein]]|cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A10 protein],,,PMID:16595661,https://www.ncbi.nlm.nih.gov/pubmed/16595661,16595661,,
18,1376474,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,1468,SLC25A10,https://ctdbase.org/detail.go?type=gene&acc=1468,,,1468.0,SLC25A10,10116,Rattus norvegicus (Norway rat),Trientine inhibits the reaction [streptozocin results in increased expression of SLC25A10 protein]|streptozocin results in increased expression of SLC25A10 protein,,,PMID:19634143,https://www.ncbi.nlm.nih.gov/pubmed/19634143,19634143,,
19,1376475,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,60386,SLC25A19,https://ctdbase.org/detail.go?type=gene&acc=60386,,,60386.0,SLC25A19,9606,Homo sapiens (human),Tin mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A19 protein]]|hmox1 protein inhibits the reaction [streptozocin results in decreased expression of SLC25A19 protein]|cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A19 protein]|streptozocin results in decreased expression of SLC25A19 protein,,,PMID:16595661,https://www.ncbi.nlm.nih.gov/pubmed/16595661,16595661,,
20,1376476,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,788,SLC25A20,https://ctdbase.org/detail.go?type=gene&acc=788,,,788.0,SLC25A20,10116,Rattus norvegicus (Norway rat),Tin mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A20 protein]]|cobaltiprotoporphyrin inhibits the reaction [streptozocin results in decreased expression of SLC25A20 protein]|streptozocin results in decreased expression of SLC25A20 protein,,,PMID:16595661,https://www.ncbi.nlm.nih.gov/pubmed/16595661,16595661,,
21,1376477,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,115286,SLC25A26,https://ctdbase.org/detail.go?type=gene&acc=115286,,,115286.0,SLC25A26,10090,Mus musculus (house mouse),Streptozocin affects the expression of SLC25A26 mRNA,,,PMID:18583417,https://www.ncbi.nlm.nih.gov/pubmed/18583417,18583417,,
22,1376478,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,5250,SLC25A3,https://ctdbase.org/detail.go?type=gene&acc=5250,,,5250.0,SLC25A3,10116,Rattus norvegicus (Norway rat),Streptozocin results in increased expression of SLC25A3 protein|trientine inhibits the reaction [streptozocin results in increased expression of SLC25A3 protein],,,PMID:19634143,https://www.ncbi.nlm.nih.gov/pubmed/19634143,19634143,,
23,1376479,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,291,SLC25A4,https://ctdbase.org/detail.go?type=gene&acc=291,,,291.0,SLC25A4,10090,Mus musculus (house mouse),SLC25A4 protein inhibits the reaction [streptozocin results in increased expression of NPPA mrna],,,PMID:18945756,https://www.ncbi.nlm.nih.gov/pubmed/18945756,18945756,,
24,1376480,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,283600,SLC25A47,https://ctdbase.org/detail.go?type=gene&acc=283600,,,283600.0,SLC25A47,10090,Mus musculus (house mouse),Streptozocin affects the expression of SLC25A47 mRNA,,,PMID:18583417,https://www.ncbi.nlm.nih.gov/pubmed/18583417,18583417,,
25,1376481,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,292,SLC25A5,https://ctdbase.org/detail.go?type=gene&acc=292,,,292.0,SLC25A5,10116,Rattus norvegicus (Norway rat),Streptozocin results in increased expression of SLC25A5 protein|trientine inhibits the reaction [streptozocin results in increased expression of SLC25A5 protein],,,PMID:19634143,https://www.ncbi.nlm.nih.gov/pubmed/19634143,19634143,,
26,1377556,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6623,SNCG,https://ctdbase.org/detail.go?type=gene&acc=6623,,,6623.0,SNCG,10116,Rattus norvegicus (Norway rat),Vanadyl sulfate inhibits the reaction [streptozocin results in increased expression of SNCG mrna]|streptozocin results in increased expression of SNCG mRNA,,,PMID:16684804,https://www.ncbi.nlm.nih.gov/pubmed/16684804,16684804,,
27,1377557,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,6079,SNORD15A,https://ctdbase.org/detail.go?type=gene&acc=6079,,,6079.0,SNORD15A,10090,Mus musculus (house mouse),Streptozocin results in increased expression of SNORD15A mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
28,1377558,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,26800,SNORD49A,https://ctdbase.org/detail.go?type=gene&acc=26800,,,26800.0,SNORD49A,10090,Mus musculus (house mouse),Streptozocin results in increased expression of SNORD49A mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
29,1377559,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,29934,SNX12,https://ctdbase.org/detail.go?type=gene&acc=29934,,,29934.0,SNX12,10116,Rattus norvegicus (Norway rat),Streptozocin results in decreased expression of SNX12 protein|[antagomirs results in decreased expression of MIR140 mrna] inhibits the reaction [streptozocin results in decreased expression of SNX12 protein]|isoflurane promotes the reaction [streptozocin results in decreased expression of SNX12 protein],,,PMID:32062618,https://www.ncbi.nlm.nih.gov/pubmed/32062618,32062618,,
30,1377560,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,9021,SOCS3,https://ctdbase.org/detail.go?type=gene&acc=9021,,,9021.0,SOCS3,10116,Rattus norvegicus (Norway rat),Streptozocin results in decreased expression of SOCS3 protein|rosiglitazone inhibits the reaction [streptozocin results in decreased expression of SOCS3 protein],,,PMID:21599458,https://www.ncbi.nlm.nih.gov/pubmed/21599458,21599458,,
31,1377561,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,692639,SOD,https://ctdbase.org/detail.go?type=gene&acc=692639,,,692639.0,SOD,6990,Nauphoeta cinerea (gray cockroach),Streptozocin results in increased expression of SOD mRNA,,,PMID:34166651,https://www.ncbi.nlm.nih.gov/pubmed/34166651,34166651,,
32,1376752,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,26515,TIMM10B,https://ctdbase.org/detail.go?type=gene&acc=26515,,,26515.0,TIMM10B,10090,Mus musculus (house mouse),Tetrachloroethylene results in decreased expression of TIMM10B mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
33,1376753,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,26517,TIMM13,https://ctdbase.org/detail.go?type=gene&acc=26517,,,26517.0,TIMM13,10090,Mus musculus (house mouse),Tetrachloroethylene results in decreased expression of TIMM13 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
34,1376754,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,7078,TIMP3,https://ctdbase.org/detail.go?type=gene&acc=7078,,,7078.0,TIMP3,10090,Mus musculus (house mouse),Tetrachloroethylene results in decreased expression of TIMP3 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
35,1376755,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,148534,TLCD4,https://ctdbase.org/detail.go?type=gene&acc=148534,,,148534.0,TLCD4,10090,Mus musculus (house mouse),Tetrachloroethylene results in increased expression of TLCD4 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
36,1376756,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,7089,TLE2,https://ctdbase.org/detail.go?type=gene&acc=7089,,,7089.0,TLE2,10090,Mus musculus (house mouse),Tetrachloroethylene results in decreased expression of TLE2 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
37,1376757,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,279572,TLR13,https://ctdbase.org/detail.go?type=gene&acc=279572,,,279572.0,Tlr13,10090,Mus musculus (house mouse),Tetrachloroethylene results in increased expression of TLR13 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
38,1376758,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,51311,TLR8,https://ctdbase.org/detail.go?type=gene&acc=51311,,,51311.0,TLR8,10090,Mus musculus (house mouse),Tetrachloroethylene results in increased expression of TLR8 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
39,1376759,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,7104,TM4SF4,https://ctdbase.org/detail.go?type=gene&acc=7104,,,7104.0,TM4SF4,10090,Mus musculus (house mouse),Tetrachloroethylene results in decreased expression of TM4SF4 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
40,1376760,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,79905,TMC7,https://ctdbase.org/detail.go?type=gene&acc=79905,,,79905.0,TMC7,10090,Mus musculus (house mouse),Tetrachloroethylene results in increased expression of TMC7 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
41,1376761,31373,Comparative Toxicogenomics Database (CTD),Tetrachloroethylene,D013750,Tetrachloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D013750,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999.0,TMED5,10090,Mus musculus (house mouse),Tetrachloroethylene results in increased expression of TMED5 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
42,1376363,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7056,THBD,https://ctdbase.org/detail.go?type=gene&acc=7056,,,7056.0,THBD,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin results in increased expression of THBD mrna],,,PMID:20493886,https://www.ncbi.nlm.nih.gov/pubmed/20493886,20493886,,
43,1376364,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7056,THBD,https://ctdbase.org/detail.go?type=gene&acc=7056,,,7056.0,THBD,9606,Homo sapiens (human),Simvastatin results in increased expression of THBD mRNA,,,PMID:14630613|PMID:20493886|PMID:20737288,https://www.ncbi.nlm.nih.gov/pubmed/14630613|https://www.ncbi.nlm.nih.gov/pubmed/20493886|https://www.ncbi.nlm.nih.gov/pubmed/20737288,14630613|20493886|20737288,,
44,1376608,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Geranylgeranyl pyrophosphate inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of IL6 mrna]]|geranylgeranyl pyrophosphate inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of CXCL8 mrna]]|simvastatin inhibits the reaction [TNF results in increased secretion of CXCL8 protein],,,PMID:16511915,https://www.ncbi.nlm.nih.gov/pubmed/16511915,16511915,,
45,1376609,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982.0,TNFRSF11B,9606,Homo sapiens (human),Simvastatin results in increased expression of TNFRSF11B mRNA,,,PMID:21431270,https://www.ncbi.nlm.nih.gov/pubmed/21431270,21431270,,
46,1376610,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Simvastatin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]|simvastatin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of BIRC3 protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of CFLAR protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]|simvastatin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of PTGS2 mrna]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]]|simvastatin inhibits the reaction [TNF protein results in increased expression of BIRC5 protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]|simvastatin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]|simvastatin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of CCND1 protein]|simvastatin inhibits the reaction [TNF protein results in increased phosphorylation of and affects the localization of RELA protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein]|simvastatin inhibits the reaction [TNF protein results in increased expression of VEGFA protein],,,PMID:17277159,https://www.ncbi.nlm.nih.gov/pubmed/17277159,17277159,,
47,1376611,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mrna]]|simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mrna],,,PMID:12117737|PMID:16321392,https://www.ncbi.nlm.nih.gov/pubmed/12117737|https://www.ncbi.nlm.nih.gov/pubmed/16321392,12117737|16321392,,
48,1376612,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Simvastatin inhibits the reaction [TNF results in increased secretion of CCL2 protein]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of CCR4 mrna]]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of CCL4 mrna]]|simvastatin inhibits the reaction [TNF results in increased secretion of CCL4 mrna]|simvastatin inhibits the reaction [TNF results in increased expression of CCR4 mrna],,,PMID:16321392,https://www.ncbi.nlm.nih.gov/pubmed/16321392,16321392,,
49,1376613,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of IL6 mrna]]|simvastatin inhibits the reaction [TNF results in increased expression of CXCL8 mrna]|simvastatin inhibits the reaction [TNF results in increased expression of IL6 mrna]|mevalonic acid inhibits the reaction [simvastatin inhibits the reaction [TNF results in increased expression of CXCL8 mrna]],,,PMID:12117737|PMID:16511915,https://www.ncbi.nlm.nih.gov/pubmed/12117737|https://www.ncbi.nlm.nih.gov/pubmed/16511915,12117737|16511915,,
50,1377697,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),Simvastatin inhibits the reaction [TNF protein results in increased expression of VEGFA protein],,,PMID:17277159,https://www.ncbi.nlm.nih.gov/pubmed/17277159,17277159,,
51,1377698,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),Simvastatin results in increased expression of VEGFA,,,PMID:20381859,https://www.ncbi.nlm.nih.gov/pubmed/20381859,20381859,,
52,1377699,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090,Mus musculus (house mouse),Simvastatin results in increased expression of VEGFA mRNA,,,PMID:15572054|PMID:18316203,https://www.ncbi.nlm.nih.gov/pubmed/15572054|https://www.ncbi.nlm.nih.gov/pubmed/18316203,15572054|18316203,,
53,1377700,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090,Mus musculus (house mouse),Simvastatin results in increased expression of VEGFA protein,,,PMID:18316203,https://www.ncbi.nlm.nih.gov/pubmed/18316203,18316203,,
54,1377701,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9986,Oryctolagus cuniculus (rabbit),Simvastatin inhibits the reaction [dietary fats results in increased expression of VEGFA protein],,,PMID:19802540,https://www.ncbi.nlm.nih.gov/pubmed/19802540,19802540,,
55,1374149,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,5168,ENPP2,https://ctdbase.org/detail.go?type=gene&acc=5168,,,5168.0,ENPP2,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of ENPP2 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
56,1374150,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,5168,ENPP2,https://ctdbase.org/detail.go?type=gene&acc=5168,,,5168.0,ENPP2,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR1 protein] results in increased expression of ENPP2 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
57,1374151,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,954,ENTPD2,https://ctdbase.org/detail.go?type=gene&acc=954,,,954.0,ENTPD2,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride results in increased expression of ENTPD2 mRNA,,,PMID:15576828,https://www.ncbi.nlm.nih.gov/pubmed/15576828,15576828,,
58,1374152,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,4072,EPCAM,https://ctdbase.org/detail.go?type=gene&acc=4072,,,4072.0,EPCAM,10090,Mus musculus (house mouse),[APC protein affects the susceptibility to raloxifene hydrochloride] which affects the expression of EPCAM mrna|[apc protein affects the susceptibility to raloxifene hydrochloride] which affects the expression of EPCAM protein,,,PMID:24431404,https://www.ncbi.nlm.nih.gov/pubmed/24431404,24431404,,
59,1374516,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride metabolite binds to ESR1 protein,,,PMID:16790557,https://www.ncbi.nlm.nih.gov/pubmed/16790557,16790557,,
60,1374517,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9823,Sus scrofa (pig),Raloxifene hydrochloride affects the expression of ESR1 protein,,,PMID:15653758|PMID:16680078,https://www.ncbi.nlm.nih.gov/pubmed/15653758|https://www.ncbi.nlm.nih.gov/pubmed/16680078,15653758|16680078,,
61,1374518,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9823,Sus scrofa (pig),Raloxifene hydrochloride results in decreased expression of ESR1 protein alternative form,,,PMID:17348974,https://www.ncbi.nlm.nih.gov/pubmed/17348974,17348974,,
62,1374519,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Raloxifene hydrochloride binds to ESR1 protein,,,PMID:16679488,https://www.ncbi.nlm.nih.gov/pubmed/16679488,16679488,,
63,1374520,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),[ESR1 protein co-treated with ESR2 protein] affects the reaction [raloxifene hydrochloride results in increased cleavage of PARP1 protein],,,PMID:22965848,https://www.ncbi.nlm.nih.gov/pubmed/22965848,22965848,,
64,1374968,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2160,F11,https://ctdbase.org/detail.go?type=gene&acc=2160,,,2160.0,F11,9606,Homo sapiens (human),Raloxifene hydrochloride results in increased activity of F11 protein,,,PMID:16359964,https://www.ncbi.nlm.nih.gov/pubmed/16359964,16359964,,
65,1374969,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Raloxifene hydrochloride results in increased expression of ESR2 protein|[trichostatin A co-treated with estradiol co-treated with raloxifene hydrochloride] results in increased expression of ESR2 protein|[trichostatin A co-treated with raloxifene hydrochloride] results in increased expression of ESR2 protein|[trichostatin A co-treated with raloxifene hydrochloride] results in increased expression of ESR2 mrna|raloxifene hydrochloride promotes the reaction [[trichostatin A co-treated with estradiol] results in increased expression of ESR2 mrna],,,PMID:22476901,https://www.ncbi.nlm.nih.gov/pubmed/22476901,22476901,,
66,1374970,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Raloxifene hydrochloride results in decreased activity of ESR2 protein,,,PMID:17654759,https://www.ncbi.nlm.nih.gov/pubmed/17654759,17654759,,
67,1374971,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Raloxifene hydrochloride results in increased activity of ESR2 protein,,,PMID:17962382,https://www.ncbi.nlm.nih.gov/pubmed/17962382,17962382,,
68,1374972,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090,Mus musculus (house mouse),[APC protein affects the susceptibility to raloxifene hydrochloride] which affects the expression of ESR2 protein,,,PMID:24431404,https://www.ncbi.nlm.nih.gov/pubmed/24431404,24431404,,
69,1374973,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090,Mus musculus (house mouse),ESR2 protein affects the reaction [raloxifene hydrochloride inhibits the reaction [streptozocin results in decreased secretion of MMP2 protein]],,,PMID:23471663,https://www.ncbi.nlm.nih.gov/pubmed/23471663,23471663,,
70,1374974,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090,Mus musculus (house mouse),Raloxifene hydrochloride binds to and affects the activity of ESR2 protein alternative form,,,PMID:15924412,https://www.ncbi.nlm.nih.gov/pubmed/15924412,15924412,,
71,1374975,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090,Mus musculus (house mouse),Raloxifene hydrochloride inhibits the reaction [oxygen deficiency results in increased expression of ESR2 protein]|raloxifene hydrochloride inhibits the reaction [oxygen deficiency results in increased expression of ESR2 mrna],,,PMID:24846829,https://www.ncbi.nlm.nih.gov/pubmed/24846829,24846829,,
72,1375455,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2287,FKBP3,https://ctdbase.org/detail.go?type=gene&acc=2287,,,2287.0,FKBP3,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of FKBP3 mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
73,1375575,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,3170,FOXA2,https://ctdbase.org/detail.go?type=gene&acc=3170,,,3170.0,FOXA2,9606,Homo sapiens (human),Raloxifene hydrochloride results in increased expression of FOXA2 mRNA,,,PMID:23184660,https://www.ncbi.nlm.nih.gov/pubmed/23184660,23184660,,
74,1375576,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2296,FOXC1,https://ctdbase.org/detail.go?type=gene&acc=2296,,,2296.0,FOXC1,9606,Homo sapiens (human),Raloxifene hydrochloride results in decreased expression of FOXC1 mRNA,,,PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/26865669,26865669,,
75,1375577,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2304,FOXE1,https://ctdbase.org/detail.go?type=gene&acc=2304,,,2304.0,FOXE1,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of FOXE1 mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
76,1375578,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of FOXO1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
77,1375579,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of FOXO1 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
78,1375580,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606,Homo sapiens (human),Raloxifene hydrochloride affects the localization of FOXO3 protein|esr1 protein affects the reaction [raloxifene hydrochloride affects the localization of FOXO3 protein]|gper1 protein affects the reaction [raloxifene hydrochloride affects the localization of FOXO3 protein],,,PMID:26470790,https://www.ncbi.nlm.nih.gov/pubmed/26470790,26470790,,
79,1375581,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,10468,FST,https://ctdbase.org/detail.go?type=gene&acc=10468,,,10468.0,FST,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of FST mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
80,1375582,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,10468,FST,https://ctdbase.org/detail.go?type=gene&acc=10468,,,10468.0,FST,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of FST mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
81,1377432,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),Raloxifene hydrochloride inhibits the reaction [IL1B protein results in increased expression of CXCL5 mrna]|raloxifene hydrochloride inhibits the reaction [IL1B protein results in increased expression of BCL3 mrna]|raloxifene hydrochloride inhibits the reaction [IL1B protein results in increased expression of CISH mrna]|[raloxifene hydrochloride co-treated with IL1B protein] results in increased expression of PTGDS mrna|raloxifene hydrochloride inhibits the reaction [IL1B protein results in increased expression of PLK3 mrna],,,PMID:12072388,https://www.ncbi.nlm.nih.gov/pubmed/12072388,12072388,,
82,1374456,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,2266,FGG,https://ctdbase.org/detail.go?type=gene&acc=2266,,,2266.0,FGG,90988,Pimephales promelas (fathead minnow),Trenbolone acetate affects the expression of FGG protein,,,PMID:24072461,https://www.ncbi.nlm.nih.gov/pubmed/24072461,24072461,,
83,1374457,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,2592,GALT,https://ctdbase.org/detail.go?type=gene&acc=2592,,,2592.0,GALT,37273,Gambusia holbrooki (eastern mosquitofish),Trenbolone acetate results in increased expression of GALT mRNA,,,PMID:25198161,https://www.ncbi.nlm.nih.gov/pubmed/25198161,25198161,,
84,1374697,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,3796,KIF2A,https://ctdbase.org/detail.go?type=gene&acc=3796,,,3796.0,KIF2A,37273,Gambusia holbrooki (eastern mosquitofish),Trenbolone acetate results in increased expression of KIF2A mRNA,,,PMID:25198161,https://www.ncbi.nlm.nih.gov/pubmed/25198161,25198161,,
85,1374698,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,17703,MSX3,https://ctdbase.org/detail.go?type=gene&acc=17703,,,17703.0,Msx3,37273,Gambusia holbrooki (eastern mosquitofish),Trenbolone acetate results in increased expression of MSX3 mRNA,,,PMID:23314276,https://www.ncbi.nlm.nih.gov/pubmed/23314276,23314276,,
86,1374699,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,389125,MUSTN1,https://ctdbase.org/detail.go?type=gene&acc=389125,,,389125.0,MUSTN1,37273,Gambusia holbrooki (eastern mosquitofish),Trenbolone acetate results in increased expression of MUSTN1 mRNA,,,PMID:25198161,https://www.ncbi.nlm.nih.gov/pubmed/25198161,25198161,,
87,1374700,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,100195065,NP1L1,https://ctdbase.org/detail.go?type=gene&acc=100195065,,,100195065.0,,37273,Gambusia holbrooki (eastern mosquitofish),Trenbolone acetate results in decreased expression of NP1L1 mRNA,,,PMID:25198161,https://www.ncbi.nlm.nih.gov/pubmed/25198161,25198161,,
88,1374701,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606,Homo sapiens (human),Trenbolone acetate binds to and results in increased activity of NR1I2 protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
89,1374702,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,10116,Rattus norvegicus (Norway rat),Trenbolone acetate results in increased expression of ODC1 mRNA,,,PMID:17688994,https://www.ncbi.nlm.nih.gov/pubmed/17688994,17688994,,
90,1374703,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,8613,PLPP3,https://ctdbase.org/detail.go?type=gene&acc=8613,,,8613.0,PLPP3,37273,Gambusia holbrooki (eastern mosquitofish),Trenbolone acetate results in increased expression of PLPP3 mRNA,,,PMID:25198161,https://www.ncbi.nlm.nih.gov/pubmed/25198161,25198161,,
91,1374704,66359,Comparative Toxicogenomics Database (CTD),Trenbolone Acetate,D014204,Trenbolone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D014204,57125,PLXDC1,https://ctdbase.org/detail.go?type=gene&acc=57125,,,57125.0,PLXDC1,37273,Gambusia holbrooki (eastern mosquitofish),Trenbolone acetate results in decreased expression of PLXDC1 mRNA,,,PMID:25198161,https://www.ncbi.nlm.nih.gov/pubmed/25198161,25198161,,
92,1366629,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,180803,C26B9.5,https://ctdbase.org/detail.go?type=gene&acc=180803,,,180803.0,C26B9.5,6239,Caenorhabditis elegans,Mianserin results in increased expression of C26B9.5 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
93,1366630,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,182965,C27D9.2,https://ctdbase.org/detail.go?type=gene&acc=182965,,,182965.0,C27D9.2,6239,Caenorhabditis elegans,Mianserin results in decreased expression of C27D9.2 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
94,1366631,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,175675,C27F2.10,https://ctdbase.org/detail.go?type=gene&acc=175675,,,175675.0,C27F2.10,6239,Caenorhabditis elegans,Mianserin results in increased expression of C27F2.10 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
95,1374521,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,6418659,T12B5.15,https://ctdbase.org/detail.go?type=gene&acc=6418659,,,6418659.0,T12B5.15,6239,Caenorhabditis elegans,Mianserin results in increased expression of T12B5.15 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
96,1374522,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,178138,T12G3.6,https://ctdbase.org/detail.go?type=gene&acc=178138,,,178138.0,T12G3.6,6239,Caenorhabditis elegans,Mianserin results in increased expression of T12G3.6 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
97,1374523,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,188503,T14G8.4,https://ctdbase.org/detail.go?type=gene&acc=188503,,,188503.0,T14G8.4,6239,Caenorhabditis elegans,Mianserin results in decreased expression of T14G8.4 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
98,1376614,68848,Comparative Toxicogenomics Database (CTD),Mesulergine,C031649,mesulergine,https://ctdbase.org/detail.go?type=chem&acc=C031649,3358,HTR2C,https://ctdbase.org/detail.go?type=gene&acc=3358,,,3358.0,HTR2C,10116,Rattus norvegicus (Norway rat),Plant extracts inhibits the reaction [pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]]|pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]|carbamazepine inhibits the reaction [pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]],,,PMID:19439326,https://www.ncbi.nlm.nih.gov/pubmed/19439326,19439326,,
99,1376615,68848,Comparative Toxicogenomics Database (CTD),Mesulergine,C031649,mesulergine,https://ctdbase.org/detail.go?type=chem&acc=C031649,3358,HTR2C,https://ctdbase.org/detail.go?type=gene&acc=3358,,,3358.0,HTR2C,10116,Rattus norvegicus (Norway rat),Mesulergine binds to HTR2C protein,,,PMID:19439326|PMID:19700373,https://www.ncbi.nlm.nih.gov/pubmed/19439326|https://www.ncbi.nlm.nih.gov/pubmed/19700373,19439326|19700373,,
100,1376616,68848,Comparative Toxicogenomics Database (CTD),Mesulergine,C031649,mesulergine,https://ctdbase.org/detail.go?type=chem&acc=C031649,3358,HTR2C,https://ctdbase.org/detail.go?type=gene&acc=3358,,,3358.0,HTR2C,9823,Sus scrofa (pig),"8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine inhibits the reaction [mesulergine binds to HTR2C protein]|mesulergine binds to HTR2C protein",,,PMID:11927170,https://www.ncbi.nlm.nih.gov/pubmed/11927170,11927170,,
101,1376617,68848,Comparative Toxicogenomics Database (CTD),Mesulergine,C031649,mesulergine,https://ctdbase.org/detail.go?type=chem&acc=C031649,3363,HTR7,https://ctdbase.org/detail.go?type=gene&acc=3363,,,3363.0,HTR7,9606,Homo sapiens (human),[mesulergine binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of cyclic AMP],,,PMID:14578406,https://www.ncbi.nlm.nih.gov/pubmed/14578406,14578406,,
102,1377054,70761,Comparative Toxicogenomics Database (CTD),4-Ethylcatechol,C527200,4-ethylcatechol,https://ctdbase.org/detail.go?type=chem&acc=C527200,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),4-ethylcatechol results in increased expression of NFE2L2 mRNA,,,PMID:26862668,https://www.ncbi.nlm.nih.gov/pubmed/26862668,26862668,,
103,1377055,70945,BindingDB,"2-Methylcyclohexane-1,3-dione",22772,"2-methylcyclohexane-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22772,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
104,1377056,70945,BindingDB,"2-Methylcyclohexane-1,3-dione",22772,"2-methylcyclohexane-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22772,2315,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2315,P12337,Liver carboxylesterase 1,100009551.0,CES1,9986,Oryctolagus cuniculus (rabbit),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
105,1377057,70945,BindingDB,"2-Methylcyclohexane-1,3-dione",22772,"2-methylcyclohexane-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22772,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
106,1377058,70945,BindingDB,"2-Methylcyclohexane-1,3-dione",22772,"2-methylcyclohexane-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22772,7016,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7016,P23141,Liver carboxylesterase 1,1066.0,CES1,9606,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
107,1377176,71060,Drug Gene Interaction database (DGIdb),Naphthol AS-BI,,CHEMBL:CHEMBL1543865,https://www.dgidb.org/drugs/chembl:CHEMBL1543865,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606,Homo sapiens (human),,,,,,,,
108,1377177,71080,Drug Gene Interaction database (DGIdb),D-alanine,,D-ALANINE,https://www.dgidb.org/drugs/drugbank:DB01786,,RGS4,https://www.dgidb.org/genes/hgnc:10000,,,5999.0,RGS4,9606,Homo sapiens (human),,,,,,,,
109,1377178,71158,DrugBank,Acamprosate,DB00659,Acamprosate,https://www.drugbank.ca/drugs/DB00659,BE0004852,"Glutamate receptor ionotropic, NMDA 1",https://www.drugbank.ca/bio_entities/BE0004852,Q05586,"Glutamate receptor ionotropic, NMDA 1",2902.0,GRIN1,9606,Homo sapiens (human),Antagonist,,,PMID:18540918|PMID:22346357|PMID:23278595|PMID:11111840,https://www.ncbi.nlm.nih.gov/pubmed/18540918|https://www.ncbi.nlm.nih.gov/pubmed/22346357|https://www.ncbi.nlm.nih.gov/pubmed/23278595|https://www.ncbi.nlm.nih.gov/pubmed/11111840,18540918|22346357|23278595|11111840,,
110,1376214,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,1468,SLC25A10,https://ctdbase.org/detail.go?type=gene&acc=1468,,,1468.0,SLC25A10,9606,Homo sapiens (human),Tetrahydropalmatine results in increased expression of SLC25A10 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
111,1376215,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,8467,SMARCA5,https://ctdbase.org/detail.go?type=gene&acc=8467,,,8467.0,SMARCA5,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of SMARCA5 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
112,1376216,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,6611,SMS,https://ctdbase.org/detail.go?type=gene&acc=6611,,,6611.0,SMS,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of SMS protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
113,1376217,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,6623,SNCG,https://ctdbase.org/detail.go?type=gene&acc=6623,,,6623.0,SNCG,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of SNCG protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
114,1376218,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,6635,SNRPE,https://ctdbase.org/detail.go?type=gene&acc=6635,,,6635.0,SNRPE,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of SNRPE protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
115,1376219,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,22938,SNW1,https://ctdbase.org/detail.go?type=gene&acc=22938,,,22938.0,SNW1,9606,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of SNW1 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
116,1375716,73293,BindingDB,"3-Aza-13-azoniapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4,6,8,11,14,16,18-nonaen-20-one",59087,CHEMBL258765,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=59087,799,Cyclin-dependent kinase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=799,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606,Homo sapiens (human),,IC50 (nM),3.5e+2,PMID:15123247|DOI:10.1016/j.chembiol.2004.03.022,https://www.ncbi.nlm.nih.gov/pubmed/15123247|https://doi.org/10.1016/j.chembiol.2004.03.022,15123247,10.1016/j.chembiol.2004.03.022,
117,1375717,73293,BindingDB,"3-Aza-13-azoniapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4,6,8,11,14,16,18-nonaen-20-one",59087,CHEMBL258765,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=59087,796,Cyclin-dependent kinase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=796,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:15123247|DOI:10.1016/j.chembiol.2004.03.022,https://www.ncbi.nlm.nih.gov/pubmed/15123247|https://doi.org/10.1016/j.chembiol.2004.03.022,15123247,10.1016/j.chembiol.2004.03.022,
118,1375718,73293,BindingDB,"3-Aza-13-azoniapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4,6,8,11,14,16,18-nonaen-20-one",59087,CHEMBL258765,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=59087,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),9960,PMID:32803196|DOI:10.1101/2020.07.17.207019,https://www.ncbi.nlm.nih.gov/pubmed/32803196|https://doi.org/10.1101/2020.07.17.207019,32803196,10.1101/2020.07.17.207019,
119,1375719,73401,Comparative Toxicogenomics Database (CTD),Marrubiin,C105731,marrubiin,https://ctdbase.org/detail.go?type=chem&acc=C105731,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),CYP2C19 protein results in increased metabolism of marrubiin,,,PMID:34431289,https://www.ncbi.nlm.nih.gov/pubmed/34431289,34431289,,
120,1375720,73401,Comparative Toxicogenomics Database (CTD),Marrubiin,C105731,marrubiin,https://ctdbase.org/detail.go?type=chem&acc=C105731,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),CYP2C9 protein results in increased metabolism of marrubiin,,,PMID:34431289,https://www.ncbi.nlm.nih.gov/pubmed/34431289,34431289,,
121,1375721,73401,Comparative Toxicogenomics Database (CTD),Marrubiin,C105731,marrubiin,https://ctdbase.org/detail.go?type=chem&acc=C105731,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),CYP3A4 protein results in increased metabolism of marrubiin,,,PMID:34431289,https://www.ncbi.nlm.nih.gov/pubmed/34431289,34431289,,
122,1375722,73549,IUPHAR/BPS Guide to PHARMACOLOGY,"Indolo[2,1-b]quinazoline-6,12-dione",8224,tryptanthrin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8224,2829,"indoleamine 2,3-dioxygenase 1",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2829,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606,Homo sapiens (human),Inhibition,pKi,5.32,PMID:24099220,https://www.ncbi.nlm.nih.gov/pubmed/24099220,24099220,,
123,1376472,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9290,GPR55,https://ctdbase.org/detail.go?type=gene&acc=9290,,,9290.0,GPR55,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of GPR55 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
124,1377692,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of GSTA1 mRNA,,,PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/20936131,20936131,,
125,1377693,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of GSTA2 mRNA,,,PMID:33772556,https://www.ncbi.nlm.nih.gov/pubmed/33772556,33772556,,
126,1377694,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10090,Mus musculus (house mouse),[NR1H3 gene mutant form results in increased susceptibility to perfluorooctane sulfonic acid] which results in increased expression of GSTA2 mRNA,,,PMID:25949234,https://www.ncbi.nlm.nih.gov/pubmed/25949234,25949234,,
127,1377695,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of GSTA2 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
128,1377696,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of GSTA2 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of GSTA2 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of GSTA2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
129,1454917,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5687,PSMA6,https://ctdbase.org/detail.go?type=gene&acc=5687,,,5687.0,PSMA6,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PSMA6 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
130,1374695,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090,Mus musculus (house mouse),Bexarotene results in increased expression of FABP4 protein,,,PMID:21622945,https://www.ncbi.nlm.nih.gov/pubmed/21622945,21622945,,
131,1374696,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,9415,FADS2,https://ctdbase.org/detail.go?type=gene&acc=9415,,,9415.0,FADS2,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of FADS2 mrna|[tamoxifen co-treated with bexarotene] results in increased expression of FADS2 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
132,1375296,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,27306,HPGDS,https://ctdbase.org/detail.go?type=gene&acc=27306,,,27306.0,HPGDS,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of HPGDS mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
133,1375903,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3866,KRT15,https://ctdbase.org/detail.go?type=gene&acc=3866,,,3866.0,KRT15,9606,Homo sapiens (human),Bexarotene results in increased expression of KRT15 mRNA,,,PMID:17178900,https://www.ncbi.nlm.nih.gov/pubmed/17178900,17178900,,
134,1375904,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3872,KRT17,https://ctdbase.org/detail.go?type=gene&acc=3872,,,3872.0,KRT17,9606,Homo sapiens (human),Bexarotene results in decreased expression of KRT17 protein|bexarotene results in decreased expression of KRT17 mRNA,,,PMID:17178900,https://www.ncbi.nlm.nih.gov/pubmed/17178900,17178900,,
135,1375905,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3852,KRT5,https://ctdbase.org/detail.go?type=gene&acc=3852,,,3852.0,KRT5,9606,Homo sapiens (human),Bexarotene results in decreased expression of KRT5 mRNA,,,PMID:8853895,https://www.ncbi.nlm.nih.gov/pubmed/8853895,8853895,,
136,1375906,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,100489468,KRT62,https://ctdbase.org/detail.go?type=gene&acc=100489468,,,100489468.0,krt62,8364,Xenopus tropicalis (tropical clawed frog),Bexarotene analog results in decreased expression of KRT62 mRNA,,,PMID:28689802,https://www.ncbi.nlm.nih.gov/pubmed/28689802,28689802,,
137,1376029,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of LDHB mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
138,1376030,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3958,LGALS3,https://ctdbase.org/detail.go?type=gene&acc=3958,,,3958.0,LGALS3,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of LGALS3 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
139,1376031,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,25475,LGALS5,https://ctdbase.org/detail.go?type=gene&acc=25475,,,25475.0,Lgals5,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of LGALS5 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
140,1376032,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,10116,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in decreased expression of LIFR mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
141,1376033,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3982,LIM2,https://ctdbase.org/detail.go?type=gene&acc=3982,,,3982.0,LIM2,8364,Xenopus tropicalis (tropical clawed frog),Bexarotene analog results in decreased expression of LIM2 mRNA,,,PMID:28689802,https://www.ncbi.nlm.nih.gov/pubmed/28689802,28689802,,
142,1376034,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,43973,LIP1,https://ctdbase.org/detail.go?type=gene&acc=43973,,,43973.0,Lip1,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of LIP1 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
143,1376035,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991.0,LIPE,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of LIPE mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
144,1376036,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,3998,LMAN1,https://ctdbase.org/detail.go?type=gene&acc=3998,,,3998.0,LMAN1,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of LMAN1 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
145,1376037,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of LOX mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
146,1376038,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,4017,LOXL2,https://ctdbase.org/detail.go?type=gene&acc=4017,,,4017.0,LOXL2,9606,Homo sapiens (human),Bexarotene results in increased expression of LOXL2 mRNA,,,PMID:17178900,https://www.ncbi.nlm.nih.gov/pubmed/17178900,17178900,,
147,1376762,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,8800,PEX11A,https://ctdbase.org/detail.go?type=gene&acc=8800,,,8800.0,PEX11A,10116,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in increased expression of PEX11A mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
148,1376913,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090,Mus musculus (house mouse),Bexarotene results in increased expression of PLIN1 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
149,1376914,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5352,PLOD2,https://ctdbase.org/detail.go?type=gene&acc=5352,,,5352.0,PLOD2,9606,Homo sapiens (human),Bexarotene results in increased expression of PLOD2 mRNA,,,PMID:17178900,https://www.ncbi.nlm.nih.gov/pubmed/17178900,17178900,,
150,1376915,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,56902,PNO1,https://ctdbase.org/detail.go?type=gene&acc=56902,,,56902.0,PNO1,9606,Homo sapiens (human),Bexarotene results in decreased expression of PNO1 mRNA,,,PMID:17178900,https://www.ncbi.nlm.nih.gov/pubmed/17178900,17178900,,
151,1376916,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,10957,PNRC1,https://ctdbase.org/detail.go?type=gene&acc=10957,,,10957.0,PNRC1,9606,Homo sapiens (human),Bexarotene results in increased expression of PNRC1 mRNA,,,PMID:17178900,https://www.ncbi.nlm.nih.gov/pubmed/17178900,17178900,,
152,1376917,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5422,POLA1,https://ctdbase.org/detail.go?type=gene&acc=5422,,,5422.0,POLA1,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of POLA1 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
153,1376918,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,8364,Xenopus tropicalis (tropical clawed frog),Bexarotene analog results in decreased expression of POMC mRNA,,,PMID:28689802,https://www.ncbi.nlm.nih.gov/pubmed/28689802,28689802,,
154,1376919,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of PON1 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
155,1376920,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5447,POR,https://ctdbase.org/detail.go?type=gene&acc=5447,,,5447.0,POR,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of POR mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
156,1376921,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5516,PPP2CB,https://ctdbase.org/detail.go?type=gene&acc=5516,,,5516.0,PPP2CB,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of PPP2CB mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
157,1376922,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5518,PPP2R1A,https://ctdbase.org/detail.go?type=gene&acc=5518,,,5518.0,PPP2R1A,10116,Rattus norvegicus (Norway rat),Bexarotene results in increased expression of PPP2R1A mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
158,1376923,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,5538,PPT1,https://ctdbase.org/detail.go?type=gene&acc=5538,,,5538.0,PPT1,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of PPT1 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
159,1377852,82146,Comparative Toxicogenomics Database (CTD),Bexarotene,D000077610,Bexarotene,https://ctdbase.org/detail.go?type=chem&acc=D000077610,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,10116,Rattus norvegicus (Norway rat),Bexarotene results in decreased expression of SDC2 mRNA,,,PMID:16648578,https://www.ncbi.nlm.nih.gov/pubmed/16648578,16648578,,
160,1374805,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,MSH2,https://www.dgidb.org/genes/hgnc:7325,,,4436.0,MSH2,9606,Homo sapiens (human),,,,,,,,
161,1374806,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,PRL,https://www.dgidb.org/genes/hgnc:9445,,,5617.0,PRL,9606,Homo sapiens (human),,,,,,,,
162,1374807,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,XIAP,https://www.dgidb.org/genes/hgnc:592,,,331.0,XIAP,9606,Homo sapiens (human),,,,,,,,
163,1374808,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,HSPA8,https://www.dgidb.org/genes/hgnc:5241,,,3312.0,HSPA8,9606,Homo sapiens (human),,,,,,,,
164,1374809,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,GADD45A,https://www.dgidb.org/genes/hgnc:4095,,,1647.0,GADD45A,9606,Homo sapiens (human),,,,,,,,
165,1374810,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,H2AC25,https://www.dgidb.org/genes/hgnc:20507,,,92815.0,H2AC25,9606,Homo sapiens (human),,,,,,,,
166,1374811,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,DCBLD1,https://www.dgidb.org/genes/hgnc:21479,,,285761.0,DCBLD1,9606,Homo sapiens (human),,,,,,,,
167,1374812,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,TGM2,https://www.dgidb.org/genes/hgnc:11778,,,7052.0,TGM2,9606,Homo sapiens (human),,,,,,,,
168,1374813,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,GABPA,https://www.dgidb.org/genes/hgnc:4071,,,2551.0,GABPA,9606,Homo sapiens (human),,,,,,,,
169,1374814,84691,Drug Gene Interaction database (DGIdb),cis-Diaminodichloroplatinum,,CISPLATIN,https://www.dgidb.org/drugs/rxcui:2555,,NR1I2,https://www.dgidb.org/genes/hgnc:7968,,,8856.0,NR1I2,9606,Homo sapiens (human),,,,,,,,
170,1375297,88409,Toxin and Toxin Target Database (T3DB),Boron phosphide (BP),T3D2408,Boron phosphide,http://www.t3db.ca/toxins/T3D2408,BE0003991,"Cytochrome c oxidase subunit 7B, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003991,P24311,"Cytochrome c oxidase subunit 7B, mitochondrial",1349.0,COX7B,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
171,1375298,88409,Toxin and Toxin Target Database (T3DB),Boron phosphide (BP),T3D2408,Boron phosphide,http://www.t3db.ca/toxins/T3D2408,BE0004990,"Cytochrome c oxidase subunit 7B2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004990,Q8TF08,"Cytochrome c oxidase subunit 7B2, mitochondrial",170712.0,COX7B2,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
172,1375299,88409,Toxin and Toxin Target Database (T3DB),Boron phosphide (BP),T3D2408,Boron phosphide,http://www.t3db.ca/toxins/T3D2408,BE0003992,"Cytochrome c oxidase subunit 7C, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003992,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",1350.0,COX7C,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
173,1375300,88409,Toxin and Toxin Target Database (T3DB),Boron phosphide (BP),T3D2408,Boron phosphide,http://www.t3db.ca/toxins/T3D2408,BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003993,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",1351.0,COX8A,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
174,1375301,88409,Toxin and Toxin Target Database (T3DB),Boron phosphide (BP),T3D2408,Boron phosphide,http://www.t3db.ca/toxins/T3D2408,BE0005022,"Cytochrome c oxidase subunit 8C, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005022,Q7Z4L0,"Cytochrome c oxidase subunit 8C, mitochondrial",341947.0,COX8C,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
175,1375302,88409,Toxin and Toxin Target Database (T3DB),Boron phosphide (BP),T3D2408,Boron phosphide,http://www.t3db.ca/toxins/T3D2408,BE0005082,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005082,O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
176,1375303,88695,BindingDB,5-Iodoisatin,22815,"5-iodo-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22815,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
177,1375304,88695,BindingDB,5-Iodoisatin,22815,"5-iodo-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22815,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
178,1374458,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,664,BNIP3,https://ctdbase.org/detail.go?type=gene&acc=664,,,664.0,BNIP3,10090,Mus musculus (house mouse),"Nicotine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BNIP3 mrna]|[nicotine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of BNIP3 mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
179,1374459,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,666,BOK,https://ctdbase.org/detail.go?type=gene&acc=666,,,666.0,BOK,10090,Mus musculus (house mouse),Nicotine results in decreased expression of BOK mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
180,1374460,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,673,BRAF,https://ctdbase.org/detail.go?type=gene&acc=673,,,673.0,BRAF,10090,Mus musculus (house mouse),Nicotine results in decreased expression of BRAF mrna|nicotine results in decreased expression of BRAF protein,,,PMID:17135361,https://www.ncbi.nlm.nih.gov/pubmed/17135361,17135361,,
181,1374461,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,672,BRCA1,https://ctdbase.org/detail.go?type=gene&acc=672,,,672.0,BRCA1,9606,Homo sapiens (human),Nicotine results in decreased expression of BRCA1 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
182,1374462,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6046,BRD2,https://ctdbase.org/detail.go?type=gene&acc=6046,,,6046.0,BRD2,10090,Mus musculus (house mouse),Nicotine results in increased expression of BRD2 mRNA,,,PMID:33640489,https://www.ncbi.nlm.nih.gov/pubmed/33640489,33640489,,
183,1374966,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090,Mus musculus (house mouse),Nicotine results in decreased expression of CASP3 mrna|nicotine results in decreased expression of CASP3 protein,,,PMID:17135361,https://www.ncbi.nlm.nih.gov/pubmed/17135361,17135361,,
184,1374967,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090,Mus musculus (house mouse),Nicotine results in increased expression of CASP3 protein modified form|nicotine results in increased activity of CASP3 protein,,,PMID:15831280,https://www.ncbi.nlm.nih.gov/pubmed/15831280,15831280,,
185,1375446,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,55704,CCDC88A,https://ctdbase.org/detail.go?type=gene&acc=55704,,,55704.0,CCDC88A,10090,Mus musculus (house mouse),Nicotine results in increased expression of CCDC88A mRNA,,,PMID:17456735,https://www.ncbi.nlm.nih.gov/pubmed/17456735,17456735,,
186,1375447,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,885,CCK,https://ctdbase.org/detail.go?type=gene&acc=885,,,885.0,CCK,10090,Mus musculus (house mouse),Nicotine results in decreased expression of CCK mRNA,,,PMID:21955143,https://www.ncbi.nlm.nih.gov/pubmed/21955143,21955143,,
187,1375448,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,885,CCK,https://ctdbase.org/detail.go?type=gene&acc=885,,,885.0,CCK,9606,Homo sapiens (human),Nicotine results in increased susceptibility to CCK protein,,,PMID:18204935,https://www.ncbi.nlm.nih.gov/pubmed/18204935,18204935,,
188,1375449,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6360,CCL16,https://ctdbase.org/detail.go?type=gene&acc=6360,,,6360.0,CCL16,9606,Homo sapiens (human),Nicotine results in decreased expression of CCL16 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
189,1375450,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090,Mus musculus (house mouse),Nicotine results in decreased secretion of CCL2 protein|nicotine inhibits the reaction [lipopolysaccharides results in increased expression of CCL2 mrna]|nicotine inhibits the reaction [lipopolysaccharides results in increased secretion of CCL2 protein]|zfp36 mutant form inhibits the reaction [nicotine results in decreased expression of CCL2 mrna]|nicotine results in decreased expression of CCL2 mRNA,,,PMID:22093924,https://www.ncbi.nlm.nih.gov/pubmed/22093924,22093924,,
190,1375451,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116,Rattus norvegicus (Norway rat),Mecamylamine inhibits the reaction [nicotine results in decreased expression of CCL2 mrna]|nicotine results in decreased expression of CCL2 mRNA,,,PMID:15135227,https://www.ncbi.nlm.nih.gov/pubmed/15135227,15135227,,
191,1375452,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116,Rattus norvegicus (Norway rat),Nicotine results in decreased expression of CCL2 protein,,,PMID:15976189,https://www.ncbi.nlm.nih.gov/pubmed/15976189,15976189,,
192,1375453,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,9606,Homo sapiens (human),Nicotine results in increased expression of CCL5 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
193,1375454,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,10090,Mus musculus (house mouse),Nicotine results in increased expression of CCN1 mRNA,,,PMID:17456735,https://www.ncbi.nlm.nih.gov/pubmed/17456735,17456735,,
194,1377059,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10090,Mus musculus (house mouse),Cytisine inhibits the reaction [nicotine results in increased expression of CHRNA4 protein]|hexamethonium inhibits the reaction [nicotine results in increased expression of CHRNA4 protein]|tubocurarine inhibits the reaction [nicotine results in increased expression of CHRNA4 protein],,,PMID:7756618,https://www.ncbi.nlm.nih.gov/pubmed/7756618,7756618,,
195,1377060,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10090,Mus musculus (house mouse),[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with nicotine] inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CHRNA4 protein],,,PMID:15551346,https://www.ncbi.nlm.nih.gov/pubmed/15551346,15551346,,
196,1377061,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10090,Mus musculus (house mouse),Nicotine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein],,,PMID:19481067,https://www.ncbi.nlm.nih.gov/pubmed/19481067,19481067,,
197,1377179,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116,Rattus norvegicus (Norway rat),Bungarotoxins inhibits the reaction [nicotine results in increased expression of CHRNA4 protein]|nicotine results in increased expression of CHRNA4 protein,,,PMID:34153408,https://www.ncbi.nlm.nih.gov/pubmed/34153408,34153408,,
198,1377180,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116,Rattus norvegicus (Norway rat),Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]|cocaine inhibits the reaction [nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]],,,PMID:10336510,https://www.ncbi.nlm.nih.gov/pubmed/10336510,10336510,,
199,1377181,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116,Rattus norvegicus (Norway rat),Dihydro-beta-erythroidine analog inhibits the reaction [nicotine results in increased expression of CHRNA4 mrna],,,PMID:28555334,https://www.ncbi.nlm.nih.gov/pubmed/28555334,28555334,,
200,1377182,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116,Rattus norvegicus (Norway rat),[dihydro-beta-erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in decreased susceptibility to nicotine,,,PMID:10945867|PMID:16915382,https://www.ncbi.nlm.nih.gov/pubmed/10945867|https://www.ncbi.nlm.nih.gov/pubmed/16915382,10945867|16915382,,
201,1377183,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116,Rattus norvegicus (Norway rat),Imidacloprid analog inhibits the reaction [nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]],,,PMID:10377228,https://www.ncbi.nlm.nih.gov/pubmed/10377228,10377228,,
202,1377184,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,1137,CHRNA4,https://ctdbase.org/detail.go?type=gene&acc=1137,,,1137.0,CHRNA4,10116,Rattus norvegicus (Norway rat),Nicotine binds to [CHRNA4 protein binds to CHRNB2 protein]|nicotine analog binds to [CHRNA4 protein binds to CHRNB2 protein],,,PMID:15615518|PMID:19252481,https://www.ncbi.nlm.nih.gov/pubmed/15615518|https://www.ncbi.nlm.nih.gov/pubmed/19252481,15615518|19252481,,
203,1375115,91550,Comparative Toxicogenomics Database (CTD),Glycidamide,C071834,glycidamide,https://ctdbase.org/detail.go?type=chem&acc=C071834,155061,ZNF746,https://ctdbase.org/detail.go?type=gene&acc=155061,,,155061.0,ZNF746,9606,Homo sapiens (human),Glycidamide results in increased expression of ZNF746 mRNA,,,PMID:23287710,https://www.ncbi.nlm.nih.gov/pubmed/23287710,23287710,,
204,1375116,91613,Therapeutic Target Database (TTD),2-Methylhistamine,D0TC5E,2-methylhistamine,https://idrblab.net/ttd/data/drug/details/D0TC5E,T26500,Histamine H4 receptor (H4R),https://idrblab.net/ttd/data/target/details/T26500,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606,Homo sapiens (human),Agonist,,,,,,,
205,1375117,91626,Comparative Toxicogenomics Database (CTD),Solusprin,C010395,acetylsalicylic acid lysinate,https://ctdbase.org/detail.go?type=chem&acc=C010395,10800,CYSLTR1,https://ctdbase.org/detail.go?type=gene&acc=10800,,,10800.0,CYSLTR1,9606,Homo sapiens (human),Acetylsalicylic acid lysinate inhibits the reaction [IL4 results in increased expression of CYSLTR1 mrna],,,PMID:19767084,https://www.ncbi.nlm.nih.gov/pubmed/19767084,19767084,,
206,1375118,91626,Comparative Toxicogenomics Database (CTD),Solusprin,C010395,acetylsalicylic acid lysinate,https://ctdbase.org/detail.go?type=chem&acc=C010395,2205,FCER1A,https://ctdbase.org/detail.go?type=gene&acc=2205,,,2205.0,FCER1A,9606,Homo sapiens (human),Acetylsalicylic acid lysinate inhibits the reaction [IL4 results in increased expression of FCER1A mrna],,,PMID:19767084,https://www.ncbi.nlm.nih.gov/pubmed/19767084,19767084,,
207,1375907,91654,Toxin and Toxin Target Database (T3DB),"1,2,3-Trichlorodibenzo-p-dioxin",T3D2071,"1,2,3-Trichlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2071,BE0000337,Transthyretin,http://www.t3db.ca/biodb/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606,Homo sapiens (human),"Cdds are believed to disrupt the production, transport, and disposition of thyroid hormones. one mechanism of this involves metabolites of cdds competing with thyroxine to bind to transthyretin, decreasing serum thyroid hormone levels. this change in thyroid hormone levels has been linked to both thyroid toxicity and neurobehavioral alterations. (L628)",,,,,,,
208,1375908,91656,Comparative Toxicogenomics Database (CTD),Bitertanol,C083642,bitertanol,https://ctdbase.org/detail.go?type=chem&acc=C083642,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606,Homo sapiens (human),[prothioconazole co-treated with terbutylazine co-treated with bitertanol co-treated with cypermethrin co-treated with malathion] results in increased activity of AHR protein|bitertanol inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of AHR protein]|bitertanol results in decreased activity of AHR protein,,,PMID:25684042,https://www.ncbi.nlm.nih.gov/pubmed/25684042,25684042,,
209,1375909,91656,Comparative Toxicogenomics Database (CTD),Bitertanol,C083642,bitertanol,https://ctdbase.org/detail.go?type=chem&acc=C083642,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Bitertanol inhibits the reaction [dihydrotestosterone binds to and results in increased activity of AR protein]|[terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with malathion] results in decreased activity of AR protein|[bitertanol co-treated with propiconazole co-treated with cypermethrin] inhibits the reaction [dihydrotestosterone binds to and results in increased activity of AR protein]|[terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with malathion] inhibits the reaction [dihydrotestosterone binds to and results in increased activity of AR protein]|bitertanol inhibits the reaction [metribolone binds to and results in increased activity of AR protein],,,PMID:23871939,https://www.ncbi.nlm.nih.gov/pubmed/23871939,23871939,,
210,1375910,91656,Comparative Toxicogenomics Database (CTD),Bitertanol,C083642,bitertanol,https://ctdbase.org/detail.go?type=chem&acc=C083642,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Dihydrotestosterone inhibits the reaction [bitertanol results in increased activity of AR protein],,,PMID:15064155,https://www.ncbi.nlm.nih.gov/pubmed/15064155,15064155,,
211,1375911,91656,Comparative Toxicogenomics Database (CTD),Bitertanol,C083642,bitertanol,https://ctdbase.org/detail.go?type=chem&acc=C083642,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10116,Rattus norvegicus (Norway rat),[bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA,,,PMID:23954766,https://www.ncbi.nlm.nih.gov/pubmed/23954766,23954766,,
212,1375912,91656,Comparative Toxicogenomics Database (CTD),Bitertanol,C083642,bitertanol,https://ctdbase.org/detail.go?type=chem&acc=C083642,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116,Rattus norvegicus (Norway rat),Bitertanol results in increased expression of CYP1A1 protein|bitertanol results in increased expression of CYP1A1 mRNA,,,PMID:16971034,https://www.ncbi.nlm.nih.gov/pubmed/16971034,16971034,,
213,1375583,91820,Comparative Toxicogenomics Database (CTD),"2,4,6-Tris(2,4,6-tribromophenoxy)-1,3,5-triazine",C000591795,"2,4,6-tris(2,4,6-tribromophenoxy)-1,3,5-triazine",https://ctdbase.org/detail.go?type=chem&acc=C000591795,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166.0,PDK4,9031,Gallus gallus (chicken),"2,4,6-tris(2,4,6-tribromophenoxy)-1,3,5-triazine results in increased expression of PDK4 mRNA",,,PMID:30133003,https://www.ncbi.nlm.nih.gov/pubmed/30133003,30133003,,
214,1376210,92427,Comparative Toxicogenomics Database (CTD),Aluminum maltolate,C067527,aluminum maltolate,https://ctdbase.org/detail.go?type=chem&acc=C067527,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Aluminum maltolate results in increased expression of BAX mRNA,,,PMID:24878590|PMID:30481499,https://www.ncbi.nlm.nih.gov/pubmed/24878590|https://www.ncbi.nlm.nih.gov/pubmed/30481499,24878590|30481499,,
215,1376211,92427,Comparative Toxicogenomics Database (CTD),Aluminum maltolate,C067527,aluminum maltolate,https://ctdbase.org/detail.go?type=chem&acc=C067527,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Aluminum maltolate results in increased expression of BAX protein,,,PMID:24878590|PMID:27113042,https://www.ncbi.nlm.nih.gov/pubmed/24878590|https://www.ncbi.nlm.nih.gov/pubmed/27113042,24878590|27113042,,
216,1376212,92427,Comparative Toxicogenomics Database (CTD),Aluminum maltolate,C067527,aluminum maltolate,https://ctdbase.org/detail.go?type=chem&acc=C067527,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Folic acid inhibits the reaction [aluminum maltolate results in increased expression of BAX protein],,,PMID:27113042,https://www.ncbi.nlm.nih.gov/pubmed/27113042,27113042,,
217,1376213,92427,Comparative Toxicogenomics Database (CTD),Aluminum maltolate,C067527,aluminum maltolate,https://ctdbase.org/detail.go?type=chem&acc=C067527,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Aluminum maltolate results in increased expression of BAX mrna|hyperforin inhibits the reaction [aluminum maltolate results in increased expression of BAX mrna],,,PMID:30481499,https://www.ncbi.nlm.nih.gov/pubmed/30481499,30481499,,
218,1454602,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[peptidoglycan co-treated with polysaccharides co-treated with ozone] results in increased activity of CAT protein,,,PMID:23911887,https://www.ncbi.nlm.nih.gov/pubmed/23911887,23911887,,
219,1377433,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of ICAM1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
220,1377434,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,100005083,ICN2,https://ctdbase.org/detail.go?type=gene&acc=100005083,,,100005083.0,icn2,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ICN2 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
221,1377435,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3416,IDE,https://ctdbase.org/detail.go?type=gene&acc=3416,,,3416.0,IDE,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IDE protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
222,1377436,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3417,IDH1,https://ctdbase.org/detail.go?type=gene&acc=3417,,,3417.0,IDH1,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of IDH1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
223,1377437,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3418,IDH2,https://ctdbase.org/detail.go?type=gene&acc=3418,,,3418.0,IDH2,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of IDH2 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
224,1377438,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3419,IDH3A,https://ctdbase.org/detail.go?type=gene&acc=3419,,,3419.0,IDH3A,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IDH3A protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
225,1377439,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3421,IDH3G,https://ctdbase.org/detail.go?type=gene&acc=3421,,,3421.0,IDH3G,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IDH3G mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
226,1377440,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3422,IDI1,https://ctdbase.org/detail.go?type=gene&acc=3422,,,3422.0,IDI1,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IDI1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
227,1377441,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3620,IDO1,https://ctdbase.org/detail.go?type=gene&acc=3620,,,3620.0,IDO1,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IDO1 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
228,1377442,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,126917,IFFO2,https://ctdbase.org/detail.go?type=gene&acc=126917,,,126917.0,IFFO2,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IFFO2 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
229,1377551,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2537,IFI6,https://ctdbase.org/detail.go?type=gene&acc=2537,,,2537.0,IFI6,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IFI6 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
230,1377552,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,64135,IFIH1,https://ctdbase.org/detail.go?type=gene&acc=64135,,,64135.0,IFIH1,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of IFIH1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
231,1377553,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3434,IFIT1,https://ctdbase.org/detail.go?type=gene&acc=3434,,,3434.0,IFIT1,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IFIT1 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
232,1377554,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3434,IFIT1,https://ctdbase.org/detail.go?type=gene&acc=3434,,,3434.0,IFIT1,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IFIT1 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
233,1377555,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,3434,IFIT1,https://ctdbase.org/detail.go?type=gene&acc=3434,,,3434.0,IFIT1,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of IFIT1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
234,1377277,98570,Comparative Toxicogenomics Database (CTD),Allocryptopine,C109505,allocryptopine,https://ctdbase.org/detail.go?type=chem&acc=C109505,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Allocryptopine results in increased expression of CYP1A1 mRNA,,,PMID:21419197,https://www.ncbi.nlm.nih.gov/pubmed/21419197,21419197,,
235,1377278,98570,Comparative Toxicogenomics Database (CTD),Allocryptopine,C109505,allocryptopine,https://ctdbase.org/detail.go?type=chem&acc=C109505,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606,Homo sapiens (human),Allocryptopine results in increased expression of CYP1A2 mRNA,,,PMID:21419197,https://www.ncbi.nlm.nih.gov/pubmed/21419197,21419197,,
236,1377279,99479,Drug Gene Interaction database (DGIdb),"2,2,5,7,8-Pentamethyl-6-chromanol",,APC-100,https://www.dgidb.org/drugs/chembl:CHEMBL37676,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606,Homo sapiens (human),,,,,,,,
237,1377280,99479,Drug Gene Interaction database (DGIdb),"2,2,5,7,8-Pentamethyl-6-chromanol",,APC-100,https://www.dgidb.org/drugs/chembl:CHEMBL37676,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606,Homo sapiens (human),,,,,,,,
238,1377281,101319,BindingDB,"Anthranilic acid, N-(o-nitrophenyl)-",35898,"flufenamic acid analogue, 25",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35898,1924,Androgen receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1924,P10275,Androgen receptor,367.0,AR,9606,Homo sapiens (human),,IC50 (nM),21900,PMID:19645433|DOI:10.1021/cb900143a,https://www.ncbi.nlm.nih.gov/pubmed/19645433|https://doi.org/10.1021/cb900143a,19645433,10.1021/cb900143a,
239,1377282,101430,Drug Gene Interaction database (DGIdb),N6-Phenyladenosine,,N6-PHENYLADENOSINE,https://www.dgidb.org/drugs/chembl:CHEMBL262083,,RXFP1,https://www.dgidb.org/genes/hgnc:19718,,,59350.0,RXFP1,9606,Homo sapiens (human),,,,,,,,
240,1377283,101450,Comparative Toxicogenomics Database (CTD),Benzyl selenocyanate,C054108,benzyl selenocyanate,https://ctdbase.org/detail.go?type=chem&acc=C054108,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Benzyl selenocyanate binds to and results in decreased activity of CYP1A1 protein,,,PMID:21732699,https://www.ncbi.nlm.nih.gov/pubmed/21732699,21732699,,
241,1377284,101450,Comparative Toxicogenomics Database (CTD),Benzyl selenocyanate,C054108,benzyl selenocyanate,https://ctdbase.org/detail.go?type=chem&acc=C054108,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606,Homo sapiens (human),Benzyl selenocyanate binds to and results in decreased activity of CYP1A2 protein|benzyl selenocyanate binds to CYP1A2 protein,,,PMID:21732699,https://www.ncbi.nlm.nih.gov/pubmed/21732699,21732699,,
242,1377285,101450,Comparative Toxicogenomics Database (CTD),Benzyl selenocyanate,C054108,benzyl selenocyanate,https://ctdbase.org/detail.go?type=chem&acc=C054108,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606,Homo sapiens (human),Benzyl selenocyanate binds to and results in decreased activity of CYP1B1 protein,,,PMID:21732699,https://www.ncbi.nlm.nih.gov/pubmed/21732699,21732699,,
243,1377286,101450,Comparative Toxicogenomics Database (CTD),Benzyl selenocyanate,C054108,benzyl selenocyanate,https://ctdbase.org/detail.go?type=chem&acc=C054108,1553,CYP2A13,https://ctdbase.org/detail.go?type=gene&acc=1553,,,1553.0,CYP2A13,9606,Homo sapiens (human),Benzyl selenocyanate binds to and results in decreased activity of CYP2A13 protein,,,PMID:21732699,https://www.ncbi.nlm.nih.gov/pubmed/21732699,21732699,,
244,1454918,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606,Homo sapiens (human),Deguelin results in decreased expression of BCL2L1 protein,,,PMID:19365708|PMID:21472727|PMID:26592500,https://www.ncbi.nlm.nih.gov/pubmed/19365708|https://www.ncbi.nlm.nih.gov/pubmed/21472727|https://www.ncbi.nlm.nih.gov/pubmed/26592500,19365708|21472727|26592500,,
245,1454919,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018.0,BCL2L11,9606,Homo sapiens (human),Deguelin results in decreased expression of BCL2L11 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
246,1377851,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,56479,KCNQ5,https://ctdbase.org/detail.go?type=gene&acc=56479,,,56479.0,KCNQ5,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of KCNQ5 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
247,1499363,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,10643,IGF2BP3,https://ctdbase.org/detail.go?type=gene&acc=10643,,,10643.0,IGF2BP3,9606,Homo sapiens (human),Torcetrapib results in increased expression of IGF2BP3 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
248,1433596,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,200916,RPL22L1,https://ctdbase.org/detail.go?type=gene&acc=200916,,,200916.0,RPL22L1,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of RPL22L1 mRNA,,,PMID:22484513|PMID:23630614,https://www.ncbi.nlm.nih.gov/pubmed/22484513|https://www.ncbi.nlm.nih.gov/pubmed/23630614,22484513|23630614,,
249,1433597,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9349,RPL23,https://ctdbase.org/detail.go?type=gene&acc=9349,,,9349.0,RPL23,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RPL23 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
250,1530042,261004,DrugBank,Arsenic(III) oxide,DB01169,Arsenic trioxide,https://www.drugbank.ca/drugs/DB01169,BE0009012,Cyclin-dependent kinase inhibitor 1,https://www.drugbank.ca/bio_entities/BE0009012,P38936,Cyclin-dependent kinase inhibitor 1,1026.0,CDKN1A,9606,Homo sapiens (human),,,,PMID:20074581,https://www.ncbi.nlm.nih.gov/pubmed/20074581,20074581,,
251,1530043,261004,DrugBank,Arsenic(III) oxide,DB01169,Arsenic trioxide,https://www.drugbank.ca/drugs/DB01169,BE0002365,Histone deacetylase 1,https://www.drugbank.ca/bio_entities/BE0002365,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606,Homo sapiens (human),,,,PMID:20074581,https://www.ncbi.nlm.nih.gov/pubmed/20074581,20074581,,
252,1530044,261004,DrugBank,Arsenic(III) oxide,DB01169,Arsenic trioxide,https://www.drugbank.ca/drugs/DB01169,BE0005808,Protein PML,https://www.drugbank.ca/bio_entities/BE0005808,P29590,Protein PML,5371.0,PML,9606,Homo sapiens (human),,,,PMID:20378816,https://www.ncbi.nlm.nih.gov/pubmed/20378816,20378816,,
253,1446663,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606,Homo sapiens (human),[hydroxymethylglutaryl-coa reductase inhibitors binds to and results in decreased activity of and results in increased expression of HMGCR] which results in decreased abundance of mevalonic acid metabolite,,,PMID:30662405,https://www.ncbi.nlm.nih.gov/pubmed/30662405,30662405,,
254,1454494,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,25814,ATXN10,https://ctdbase.org/detail.go?type=gene&acc=25814,,,25814.0,ATXN10,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of ATXN10 mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
255,1454495,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,101928433,ATXN1-AS1,https://ctdbase.org/detail.go?type=gene&acc=101928433,,,101928433.0,ATXN1-AS1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ATXN1-AS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
256,1454496,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,565841,ATXN1B,https://ctdbase.org/detail.go?type=gene&acc=565841,,,565841.0,atxn1b,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATXN1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
257,1454497,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,342371,ATXN1L,https://ctdbase.org/detail.go?type=gene&acc=342371,,,342371.0,ATXN1L,9606,Homo sapiens (human),Sodium arsenite results in decreased stability of ATXN1L mRNA,,,PMID:25493608,https://www.ncbi.nlm.nih.gov/pubmed/25493608,25493608,,
258,1470156,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Ginkgo biloba extract inhibits the reaction [sodium arsenite results in increased activity of GPT protein],,,PMID:34251737,https://www.ncbi.nlm.nih.gov/pubmed/34251737,34251737,,
259,1549201,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10090,Mus musculus (house mouse),"Resveratrol inhibits the reaction [LEP protein results in increased expression of MMP13 protein]|resveratrol inhibits the reaction [dietary fats results in increased expression of MMP13 mrna]|alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [resveratrol inhibits the reaction [LEP protein results in increased expression of MMP13 protein]]|resveratrol inhibits the reaction [dietary fats results in increased expression of MMP13 protein]",,,PMID:31881177,https://www.ncbi.nlm.nih.gov/pubmed/31881177,31881177,,
260,1549202,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10090,Mus musculus (house mouse),[hyaluronic acid co-treated with resveratrol] results in decreased expression of MMP13 mRNA,,,PMID:23595953,https://www.ncbi.nlm.nih.gov/pubmed/23595953,23595953,,
261,1549203,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606,Homo sapiens (human),Resveratrol promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mrna],,,PMID:27818126,https://www.ncbi.nlm.nih.gov/pubmed/27818126,27818126,,
262,1549204,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090,Mus musculus (house mouse),Resveratrol results in increased expression of GCLM mRNA,,,PMID:25808216,https://www.ncbi.nlm.nih.gov/pubmed/25808216,25808216,,
263,1549205,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9247,GCM2,https://ctdbase.org/detail.go?type=gene&acc=9247,,,9247.0,GCM2,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of GCM2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
264,1549206,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2651,GCNT2,https://ctdbase.org/detail.go?type=gene&acc=2651,,,2651.0,GCNT2,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of GCNT2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
265,1607346,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Decitabine inhibits the reaction [benzene results in increased expression of BAX mrna],,,PMID:21143203,https://www.ncbi.nlm.nih.gov/pubmed/21143203,21143203,,
266,1607347,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,9606,Homo sapiens (human),Cannabidiol results in increased expression of COL1A1 protein,,,PMID:32656944,https://www.ncbi.nlm.nih.gov/pubmed/32656944,32656944,,
267,1607348,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,10090,Mus musculus (house mouse),Cannabidiol analog inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mrna],,,PMID:30033591,https://www.ncbi.nlm.nih.gov/pubmed/30033591,30033591,,
268,1607349,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,9606,Homo sapiens (human),Cannabidiol inhibits the reaction [TNF protein results in increased expression of COL3A1 mrna],,,PMID:31250491,https://www.ncbi.nlm.nih.gov/pubmed/31250491,31250491,,
269,1607350,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,9606,Homo sapiens (human),Cannabidiol results in increased expression of COL3A1 mRNA,,,PMID:33872753,https://www.ncbi.nlm.nih.gov/pubmed/33872753,33872753,,
270,1607351,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1282,COL4A1,https://ctdbase.org/detail.go?type=gene&acc=1282,,,1282.0,COL4A1,9606,Homo sapiens (human),Cannabidiol inhibits the reaction [TNF protein results in increased expression of COL4A1 mrna],,,PMID:31250491,https://www.ncbi.nlm.nih.gov/pubmed/31250491,31250491,,
271,1607352,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,116228,COX20,https://ctdbase.org/detail.go?type=gene&acc=116228,,,116228.0,COX20,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of COX20 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
272,1607353,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1339,COX6A2,https://ctdbase.org/detail.go?type=gene&acc=1339,,,1339.0,COX6A2,10090,Mus musculus (house mouse),Cannabidiol results in increased expression of COX6A2 mRNA,,,PMID:21542829,https://www.ncbi.nlm.nih.gov/pubmed/21542829,21542829,,
273,1607354,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,1357,CPA1,https://ctdbase.org/detail.go?type=gene&acc=1357,,,1357.0,CPA1,7955,Danio rerio (zebrafish),Cannabidiol affects the expression of CPA1 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
274,2012416,13499427,BindingDB,"3-amino-3,4-dihydroquinolin-2(1H)-one",23990,"3-amino-1,2,3,4-tetrahydroquinolin-2-one hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23990,2445,Cytosol aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2445,P00727,Cytosol aminopeptidase,781648.0,LAP3,9913,Bos taurus (cattle),,IC50 (nM),>1000000,PMID:16844380|DOI:10.1016/j.bmc.2006.06.050,https://www.ncbi.nlm.nih.gov/pubmed/16844380|https://doi.org/10.1016/j.bmc.2006.06.050,16844380,10.1016/j.bmc.2006.06.050,
275,2012417,13499427,BindingDB,"3-amino-3,4-dihydroquinolin-2(1H)-one",23990,"3-amino-1,2,3,4-tetrahydroquinolin-2-one hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23990,2448,Leukotriene A-4 hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2448,P09960,Leukotriene A-4 hydrolase,4048.0,LTA4H,9606,Homo sapiens (human),,IC50 (nM),>1000000,PMID:16844380|DOI:10.1016/j.bmc.2006.06.050,https://www.ncbi.nlm.nih.gov/pubmed/16844380|https://doi.org/10.1016/j.bmc.2006.06.050,16844380,10.1016/j.bmc.2006.06.050,
276,2012418,13578534,Therapeutic Target Database (TTD),(S)-pyrrolidin-1-yl(pyrrolidin-2-yl)methanone,D07IJU,(S)-pyrrolidin-1-yl(pyrrolidin-2-yl)methanone,https://idrblab.net/ttd/data/drug/details/D07IJU,T31391,Dipeptidyl peptidase 4 (DPP-4),https://idrblab.net/ttd/data/target/details/T31391,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606,Homo sapiens (human),Inhibitor,,,,,,,
277,2012419,13673571,BindingDB,N-(2-hydroxyphenyl)-2-[[2-[(2-hydroxyphenyl)carbamoyl]phenyl]diselanyl]benzamide,50197297,CHEMBL3928799,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50197297,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),339,,,,,
278,2012420,13818876,Drug Gene Interaction database (DGIdb),Isobicyclogermacral,,CHEMBL:CHEMBL2333548,https://www.dgidb.org/drugs/chembl:CHEMBL2333548,,MAPK1,https://www.dgidb.org/genes/hgnc:6871,,,5594.0,MAPK1,9606,Homo sapiens (human),,,,,,,,
279,2012421,13904714,Therapeutic Target Database (TTD),3-(2-Phenyl-2-(piperazin-1-yl)ethyl)phenol,D0T8BU,3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol,https://idrblab.net/ttd/data/drug/details/D0T8BU,T27812,Serotonin transporter (SERT),https://idrblab.net/ttd/data/target/details/T27812,P31645,Sodium-dependent serotonin transporter,6532.0,SLC6A4,9606,Homo sapiens (human),Inhibitor,,,,,,,
280,2012422,13904719,Therapeutic Target Database (TTD),1-(2-(3-Methoxyphenyl)-1-phenylethyl)piperazine,D08LAY,1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine,https://idrblab.net/ttd/data/drug/details/D08LAY,T21945,Norepinephrine transporter (NET),https://idrblab.net/ttd/data/target/details/T21945,P23975,Sodium-dependent noradrenaline transporter ,6530.0,SLC6A2,9606,Homo sapiens (human),Inhibitor,,,,,,,
281,2012423,13904719,Therapeutic Target Database (TTD),1-(2-(3-Methoxyphenyl)-1-phenylethyl)piperazine,D08LAY,1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine,https://idrblab.net/ttd/data/drug/details/D08LAY,T27812,Serotonin transporter (SERT),https://idrblab.net/ttd/data/target/details/T27812,P31645,Sodium-dependent serotonin transporter,6532.0,SLC6A4,9606,Homo sapiens (human),Inhibitor,,,,,,,
282,2012424,13943580,BindingDB,O-Trityl-L-serine,23805,(2S)-2-amino-3-(triphenylmethoxy)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23805,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606,Homo sapiens (human),,Ki (nM),750,PMID:18266314|DOI:10.1021/jm070606z,https://www.ncbi.nlm.nih.gov/pubmed/18266314|https://doi.org/10.1021/jm070606z,18266314,10.1021/jm070606z,
283,2012425,14081820,BindingDB,(R)-2-(tritylamino)-3-(tritylthio)propanoic acid,23809,(2R)-2-[(triphenylmethyl)amino]-3-[(triphenylmethyl)sulfanyl]propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23809,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606,Homo sapiens (human),,,,PMID:18266314|DOI:10.1021/jm070606z,https://www.ncbi.nlm.nih.gov/pubmed/18266314|https://doi.org/10.1021/jm070606z,18266314,10.1021/jm070606z,
284,2012472,15685977,Therapeutic Target Database (TTD),3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,D06VST,3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,https://idrblab.net/ttd/data/drug/details/D06VST,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606,Homo sapiens (human),Inhibitor,,,,,,,
285,2012473,15685977,Therapeutic Target Database (TTD),3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,D06VST,3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one,https://idrblab.net/ttd/data/drug/details/D06VST,T79961,Muscarinic acetylcholine receptor M5 (CHRM5),https://idrblab.net/ttd/data/target/details/T79961,P08912,Muscarinic acetylcholine receptor M5,1133.0,CHRM5,9606,Homo sapiens (human),Inhibitor,,,,,,,
286,2012474,15817161,Therapeutic Target Database (TTD),7-[3-(3-Methoxy-4-methylcarbamoyl-2-propyl-phenoxy)-propoxy]-8-propyl-chroman-2-carboxylic acid,D07EGC,SC-50073,https://idrblab.net/ttd/data/drug/details/D07EGC,T59626,Leukotriene B4 receptor 1 (LTB4R),https://idrblab.net/ttd/data/target/details/T59626,Q15722,Leukotriene B4 receptor 1,1241.0,LTB4R,9606,Homo sapiens (human),Inhibitor,,,,,,,
287,2012475,15870567,Therapeutic Target Database (TTD),5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole,D03KPA,5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole,https://idrblab.net/ttd/data/drug/details/D03KPA,T07806,5-HT 1B receptor (HTR1B),https://idrblab.net/ttd/data/target/details/T07806,P28222,5-hydroxytryptamine receptor 1B,3351.0,HTR1B,9606,Homo sapiens (human),Inhibitor,,,,,,,
288,2012476,15870567,Therapeutic Target Database (TTD),5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole,D03KPA,5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole,https://idrblab.net/ttd/data/drug/details/D03KPA,T11072,5-HT 1D receptor (HTR1D),https://idrblab.net/ttd/data/target/details/T11072,P28221,5-hydroxytryptamine receptor 1D,3352.0,HTR1D,9606,Homo sapiens (human),Inhibitor,,,,,,,
289,2012477,15908132,Therapeutic Target Database (TTD),(4-Amino-3'-chloro-biphenyl-3-yl)-dimethyl-methanol,D0N1RQ,2-(4-Amino-3'-chloro-biphenyl-3-yl)-propan-2-ol,https://idrblab.net/ttd/data/drug/details/D0N1RQ,T22939,Progesterone receptor (PGR),https://idrblab.net/ttd/data/target/details/T22939,P06401,Progesterone receptor,5241.0,PGR,9606,Homo sapiens (human),Inhibitor,,,,,,,
290,2012478,15934381,Comparative Toxicogenomics Database (CTD),Alismol,C053720,alismol,https://ctdbase.org/detail.go?type=chem&acc=C053720,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),Alismol inhibits the reaction [lipopolysaccharides results in increased expression of NOS2],,,PMID:10560729,https://www.ncbi.nlm.nih.gov/pubmed/10560729,10560729,,
291,2012479,15951053,BindingDB,"3-({12-Ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",25881,"3-({12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25881,227,Gamma-aminobutyric acid receptor subunit alpha-6 [20-453]/beta-3 [26-473]/gamma-2 [40-467],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=227,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606,Homo sapiens (human),,Ki (nM),5000,PMID:18790643|DOI:10.1016/j.bmc.2008.08.072,https://www.ncbi.nlm.nih.gov/pubmed/18790643|https://doi.org/10.1016/j.bmc.2008.08.072,18790643,10.1016/j.bmc.2008.08.072,
292,2012480,15951053,BindingDB,"3-({12-Ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",25881,"3-({12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25881,223,Gamma-aminobutyric acid receptor subunit alpha-2 [29-451]/beta-3 [26-473]/gamma-2 [40-467],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=223,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606,Homo sapiens (human),,Ki (nM),4703,PMID:18790643|DOI:10.1016/j.bmc.2008.08.072,https://www.ncbi.nlm.nih.gov/pubmed/18790643|https://doi.org/10.1016/j.bmc.2008.08.072,18790643,10.1016/j.bmc.2008.08.072,
293,2012509,15951053,BindingDB,"3-({12-Ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",25881,"3-({12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25881,222,Gamma-aminobutyric acid receptor subunit alpha-1 [28-456]/beta-3 [26-473]/gamma-2 [40-467],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=222,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606,Homo sapiens (human),,Ki (nM),1852,PMID:18790643|DOI:10.1016/j.bmc.2008.08.072,https://www.ncbi.nlm.nih.gov/pubmed/18790643|https://doi.org/10.1016/j.bmc.2008.08.072,18790643,10.1016/j.bmc.2008.08.072,
294,2012510,15951053,BindingDB,"3-({12-Ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",25881,"3-({12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25881,226,Gamma-aminobutyric acid receptor subunit alpha-5 [32-462]/beta-3 [26-473]/gamma-2 [40-467],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=226,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606,Homo sapiens (human),,Ki (nM),100.5,PMID:18790643|DOI:10.1016/j.bmc.2008.08.072,https://www.ncbi.nlm.nih.gov/pubmed/18790643|https://doi.org/10.1016/j.bmc.2008.08.072,18790643,10.1016/j.bmc.2008.08.072,
295,2012511,15951053,BindingDB,"3-({12-Ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",25881,"3-({12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaen-5-yl}carbonyloxy)propyl 12-ethyl-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25881,224,Gamma-aminobutyric acid receptor subunit alpha-3 [29-492]/beta-3 [26-473]/gamma-2 [40-467],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=224,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606,Homo sapiens (human),,Ki (nM),8545,PMID:18790643|DOI:10.1016/j.bmc.2008.08.072,https://www.ncbi.nlm.nih.gov/pubmed/18790643|https://doi.org/10.1016/j.bmc.2008.08.072,18790643,10.1016/j.bmc.2008.08.072,
296,2012512,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),Enzalutamide results in decreased expression of CCNB1 protein,,,PMID:32805266,https://www.ncbi.nlm.nih.gov/pubmed/32805266,32805266,,
297,2012513,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),[enzalutamide co-treated with GSK-2816126] results in increased cleavage of PARP1 protein,,,PMID:32805266,https://www.ncbi.nlm.nih.gov/pubmed/32805266,32805266,,
298,2012514,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,4854,NOTCH3,https://ctdbase.org/detail.go?type=gene&acc=4854,,,4854.0,NOTCH3,9606,Homo sapiens (human),Enzalutamide affects the expression of NOTCH3 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
299,2012515,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,51166,AADAT,https://ctdbase.org/detail.go?type=gene&acc=51166,,,51166.0,AADAT,9606,Homo sapiens (human),Enzalutamide results in decreased expression of AADAT mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
300,2012546,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606,Homo sapiens (human),Enzalutamide results in decreased expression of ABCC4 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
301,2012547,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,116285,ACSM1,https://ctdbase.org/detail.go?type=gene&acc=116285,,,116285.0,ACSM1,9606,Homo sapiens (human),Enzalutamide results in decreased expression of ACSM1 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
302,2012548,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,102,ADAM10,https://ctdbase.org/detail.go?type=gene&acc=102,,,102.0,ADAM10,9606,Homo sapiens (human),Enzalutamide affects the expression of ADAM10 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
303,2012549,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,6868,ADAM17,https://ctdbase.org/detail.go?type=gene&acc=6868,,,6868.0,ADAM17,9606,Homo sapiens (human),Enzalutamide affects the expression of ADAM17 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
304,2012550,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,56985,ADPRM,https://ctdbase.org/detail.go?type=gene&acc=56985,,,56985.0,ADPRM,9606,Homo sapiens (human),Enzalutamide results in decreased expression of ADPRM mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
305,2012551,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3899,AFF3,https://ctdbase.org/detail.go?type=gene&acc=3899,,,3899.0,AFF3,9606,Homo sapiens (human),Enzalutamide results in decreased expression of AFF3 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
306,2012552,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),Enzalutamide binds to ALB protein,,,PMID:31538772,https://www.ncbi.nlm.nih.gov/pubmed/31538772,31538772,,
307,2012553,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,220,ALDH1A3,https://ctdbase.org/detail.go?type=gene&acc=220,,,220.0,ALDH1A3,9606,Homo sapiens (human),Enzalutamide results in decreased expression of ALDH1A3 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
308,2012554,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,115701,ALPK2,https://ctdbase.org/detail.go?type=gene&acc=115701,,,115701.0,ALPK2,9606,Homo sapiens (human),Enzalutamide results in decreased expression of ALPK2 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
309,2012555,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,9606,Homo sapiens (human),Enzalutamide affects the expression of ANXA4 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
310,2012556,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,51107,APH1A,https://ctdbase.org/detail.go?type=gene&acc=51107,,,51107.0,APH1A,9606,Homo sapiens (human),Enzalutamide affects the expression of APH1A mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
311,2012557,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,83464,APH1B,https://ctdbase.org/detail.go?type=gene&acc=83464,,,83464.0,APH1B,9606,Homo sapiens (human),Enzalutamide affects the expression of APH1B mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
312,2012558,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),Enzalutamide affects the expression of APP mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
313,2012559,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),AR alternative form results in decreased susceptibility to enzalutamide,,,PMID:25908785,https://www.ncbi.nlm.nih.gov/pubmed/25908785,25908785,,
314,2012560,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),AR protein alternative form results in decreased susceptibility to enzalutamide|enzalutamide inhibits the reaction [dihydrotestosterone results in increased expression of AR mrna]|niclosamide inhibits the reaction [AR protein alternative form results in decreased susceptibility to enzalutamide],,,PMID:24740322,https://www.ncbi.nlm.nih.gov/pubmed/24740322,24740322,,
315,2012561,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),[nirogacestat results in increased susceptibility to enzalutamide] which results in decreased expression of AR protein|ar protein results in decreased susceptibility to enzalutamide,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
316,2012562,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Enzalutamide binds to and results in decreased localization of and results in decreased activity of AR protein,,,PMID:19359544,https://www.ncbi.nlm.nih.gov/pubmed/19359544,19359544,,
317,2012563,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),[enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]|enzalutamide results in decreased expression of AR protein alternative form,,,PMID:32805266,https://www.ncbi.nlm.nih.gov/pubmed/32805266,32805266,,
318,2012564,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),[enzalutamide co-treated with niclosamide] results in decreased expression of AR protein,,,PMID:25970160,https://www.ncbi.nlm.nih.gov/pubmed/25970160,25970160,,
319,2012565,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),[enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR protein alternative form|[enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR mRNA alternative form|[enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR mrna|[enzalutamide co-treated with NVP-BHG712] results in decreased expression of AR protein,,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
320,2012606,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Enzalutamide inhibits the reaction [dihydrotestosterone promotes the reaction [AR protein binds to MYC enhancer]],,,PMID:24759320,https://www.ncbi.nlm.nih.gov/pubmed/24759320,24759320,,
321,2012607,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Enzalutamide inhibits the reaction [dihydrotestosterone results in increased activity of AR protein],,,PMID:27994731,https://www.ncbi.nlm.nih.gov/pubmed/27994731,27994731,,
322,2012608,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Enzalutamide results in decreased activity of AR protein|ar protein mutant form results in decreased susceptibility to enzalutamide,,,PMID:28757136,https://www.ncbi.nlm.nih.gov/pubmed/28757136,28757136,,
323,2012609,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Enzalutamide results in decreased expression of AR protein,,,PMID:32805266|PMID:37019376,https://www.ncbi.nlm.nih.gov/pubmed/32805266|https://www.ncbi.nlm.nih.gov/pubmed/37019376,32805266|37019376,,
324,2012610,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Enzalutamide binds to AR protein,,,PMID:31538772,https://www.ncbi.nlm.nih.gov/pubmed/31538772,31538772,,
325,2012611,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,563,AZGP1,https://ctdbase.org/detail.go?type=gene&acc=563,,,563.0,AZGP1,9606,Homo sapiens (human),Enzalutamide results in decreased expression of AZGP1 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
326,2012612,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606,Homo sapiens (human),Enzalutamide promotes the reaction [niclosamide results in decreased expression of BIRC5 protein],,,PMID:25970160,https://www.ncbi.nlm.nih.gov/pubmed/25970160,25970160,,
327,2012613,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,658,BMPR1B,https://ctdbase.org/detail.go?type=gene&acc=658,,,658.0,BMPR1B,9606,Homo sapiens (human),Enzalutamide results in decreased expression of BMPR1B mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
328,2012614,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,105266038,BRP44,https://ctdbase.org/detail.go?type=gene&acc=105266038,,,105266038.0,,9606,Homo sapiens (human),Enzalutamide results in decreased expression of BRP44 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
329,2012615,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,79098,C1ORF116,https://ctdbase.org/detail.go?type=gene&acc=79098,,,79098.0,C1orf116,9606,Homo sapiens (human),Enzalutamide results in decreased expression of C1ORF116 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
330,2012625,16099857,BindingDB,"4-{1-ethyl-6-methoxy-1H-imidazo[4,5-c]pyridin-2-yl}-1,2,5-oxadiazol-3-amine",14033,"4-{1-ethyl-6-methoxy-1H-imidazo[4,5-c]pyridin-2-yl}-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14033,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606,Homo sapiens (human),,IC50 (nM),4.4,PMID:17201404|DOI:10.1021/jm060873p,https://www.ncbi.nlm.nih.gov/pubmed/17201404|https://doi.org/10.1021/jm060873p,17201404,10.1021/jm060873p,
331,2012626,16099858,BindingDB,"N-(4-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)acetamide",14036,Aminofurazanyl-azabenzimidazole 6d,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14036,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606,Homo sapiens (human),,IC50 (nM),90,PMID:17201404|DOI:10.1021/jm060873p,https://www.ncbi.nlm.nih.gov/pubmed/17201404|https://doi.org/10.1021/jm060873p,17201404,10.1021/jm060873p,
332,2012627,16099859,BindingDB,"N-(3-((2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl)oxy)phenyl)-4-(dimethylamino)benzamide",14041,Aminofurazanyl-azabenzimidazole 6h,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14041,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606,Homo sapiens (human),,IC50 (nM),2.0,PMID:17201404|DOI:10.1021/jm060873p,https://www.ncbi.nlm.nih.gov/pubmed/17201404|https://doi.org/10.1021/jm060873p,17201404,10.1021/jm060873p,
333,2012628,16099860,BindingDB,"N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-(aminomethyl)benzamide",14043,Aminofurazanyl-azabenzimidazole 6j,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14043,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606,Homo sapiens (human),,IC50 (nM),<1,PMID:17201404|DOI:10.1021/jm060873p,https://www.ncbi.nlm.nih.gov/pubmed/17201404|https://doi.org/10.1021/jm060873p,17201404,10.1021/jm060873p,
334,2012629,16099861,BindingDB,"N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-(morpholin-4-ylmethyl)benzamide",14045,Aminofurazanyl-azabenzimidazole 6l,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14045,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606,Homo sapiens (human),,IC50 (nM),<1,PMID:17201404|DOI:10.1021/jm060873p,https://www.ncbi.nlm.nih.gov/pubmed/17201404|https://doi.org/10.1021/jm060873p,17201404,10.1021/jm060873p,
335,2012630,16099866,BindingDB,"N-(4-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide",14054,"N-(4-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14054,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606,Homo sapiens (human),,IC50 (nM),2500,PMID:17201405|DOI:10.1021/jm0609014,https://www.ncbi.nlm.nih.gov/pubmed/17201405|https://doi.org/10.1021/jm0609014,17201405,10.1021/jm0609014,
336,2012631,16109435,IUPHAR/BPS Guide to PHARMACOLOGY,"2-cyclohexyl-5,7-di(phenyl)-1H-imidazo[4,5-b]pyridine",5607,LUF5981,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5607,18,A1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18,P30542,Adenosine receptor A1,134.0,ADORA1,9606,Homo sapiens (human),Antagonist,pKi,9.05,PMID:17300165,https://www.ncbi.nlm.nih.gov/pubmed/17300165,17300165,,
337,2012632,16118392,IUPHAR/BPS Guide to PHARMACOLOGY,Golvatinib,7956,golvatinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7956,1813,kinase insert domain receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1813,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606,Homo sapiens (human),Inhibition,pIC50,7.8,PMID:19832844,https://www.ncbi.nlm.nih.gov/pubmed/19832844,19832844,,
338,2012407,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001715,D-hydantoinase,https://www.drugbank.ca/bio_entities/BE0001715,Q45515,D-hydantoinase,,,1422,Geobacillus stearothermophilus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
339,2012408,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001641,Methylmalonyl-CoA carboxyltransferase 5S subunit,https://www.drugbank.ca/bio_entities/BE0001641,Q70AC7,Methylmalonyl-CoA carboxyltransferase 5S subunit,,,1752,Propionibacterium freudenreichii subsp. shermanii,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
340,2012409,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001801,Isoaspartyl dipeptidase,https://www.drugbank.ca/bio_entities/BE0001801,P39377,Isoaspartyl dipeptidase,948853.0,iadA,83333,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
341,2012410,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001778,Beta-lactamase OXA-2,https://www.drugbank.ca/bio_entities/BE0001778,P0A1V8,Beta-lactamase OXA-2,67369352.0,CKG22_RS08850,90371,Salmonella enterica subsp. enterica serovar Typhimurium,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
342,2012411,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001806,"Alanine racemase, catabolic",https://www.drugbank.ca/bio_entities/BE0001806,Q9HTQ2,"Alanine racemase, catabolic",878055.0,dadX,208964,Pseudomonas aeruginosa PAO1,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
343,2012412,17754066,DrugBank,Lysophosphotidylserine,DB04136,Lysophosphotidylserine,https://www.drugbank.ca/drugs/DB04136,BE0000048,Prothrombin,https://www.drugbank.ca/bio_entities/BE0000048,P00734,Prothrombin,2147.0,F2,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
344,2012413,17754068,DrugBank,"2,6-Diamino-Hexanoic Acid Amide",DB03988,"2,6-Diamino-Hexanoic Acid Amide",https://www.drugbank.ca/drugs/DB03988,BE0003199,Pituitary adenylate cyclase-activating polypeptide,https://www.drugbank.ca/bio_entities/BE0003199,P18509,Pituitary adenylate cyclase-activating polypeptide,116.0,ADCYAP1,9606,Homo sapiens (human),,,,,,,,
345,2012414,17754130,DrugBank,"(7S)-4-hydroxy-7-(octadecanoyloxy)-10-oxo-3,5,9-trioxa-4-phosphaheptacosan-1-aminium 4-oxide",DB04327,Phosphatidylethanolamine,https://www.drugbank.ca/drugs/DB04327,BE0005530,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",https://www.drugbank.ca/bio_entities/BE0005530,P60484,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",5728.0,PTEN,9606,Homo sapiens (human),Substrate,,,PMID:15313215,https://www.ncbi.nlm.nih.gov/pubmed/15313215,15313215,,
346,2012415,17754130,DrugBank,"(7S)-4-hydroxy-7-(octadecanoyloxy)-10-oxo-3,5,9-trioxa-4-phosphaheptacosan-1-aminium 4-oxide",DB04327,Phosphatidylethanolamine,https://www.drugbank.ca/drugs/DB04327,BE0001161,Endothelial protein C receptor,https://www.drugbank.ca/bio_entities/BE0001161,Q9UNN8,Endothelial protein C receptor,10544.0,PROCR,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
347,2029240,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,5168,ENPP2,https://ctdbase.org/detail.go?type=gene&acc=5168,,,5168.0,ENPP2,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of ENPP2 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
348,2029241,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,133121,ENPP6,https://ctdbase.org/detail.go?type=gene&acc=133121,,,133121.0,ENPP6,10090,Mus musculus (house mouse),Tamoxifen affects the expression of ENPP6 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
349,2029242,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10807,ENTR1,https://ctdbase.org/detail.go?type=gene&acc=10807,,,10807.0,ENTR1,10090,Mus musculus (house mouse),Tamoxifen affects the expression of ENTR1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
350,2029243,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9413,ENTREP1,https://ctdbase.org/detail.go?type=gene&acc=9413,,,9413.0,ENTREP1,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of ENTREP1 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
351,2029244,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,9606,Homo sapiens (human),Tamoxifen inhibits the reaction [ESR1 protein binds to EP300 protein],,,PMID:23665804,https://www.ncbi.nlm.nih.gov/pubmed/23665804,23665804,,
352,2029245,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,57634,EP400,https://ctdbase.org/detail.go?type=gene&acc=57634,,,57634.0,EP400,10090,Mus musculus (house mouse),Tamoxifen results in decreased expression of EP400 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
353,2029246,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2037,EPB41L2,https://ctdbase.org/detail.go?type=gene&acc=2037,,,2037.0,EPB41L2,9606,Homo sapiens (human),Tamoxifen affects the expression of EPB41L2 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
354,2029247,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,64097,EPB41L4A,https://ctdbase.org/detail.go?type=gene&acc=64097,,,64097.0,EPB41L4A,10090,Mus musculus (house mouse),Tamoxifen affects the expression of EPB41L4A mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
355,2029248,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,4072,EPCAM,https://ctdbase.org/detail.go?type=gene&acc=4072,,,4072.0,EPCAM,7955,Danio rerio (zebrafish),Tamoxifen results in increased expression of EPCAM mRNA,,,PMID:26908177,https://www.ncbi.nlm.nih.gov/pubmed/26908177,26908177,,
356,2029249,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,54749,EPDR1,https://ctdbase.org/detail.go?type=gene&acc=54749,,,54749.0,EPDR1,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of EPDR1 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
357,2002085,20347846,Therapeutic Target Database (TTD),"2-amino-2,3-dihydro-1H-indene-5-sulfonamide",D07CYN,"2-amino-2,3-dihydro-1H-indene-5-sulfonamide",https://idrblab.net/ttd/data/drug/details/D07CYN,T31992,Carbonic anhydrase XIV (CA-XIV),https://idrblab.net/ttd/data/target/details/T31992,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606,Homo sapiens (human),Inhibitor,,,,,,,
358,2002084,20910277,BindingDB,"3-[4-(Furan-2-YL)butan-2-YL]-1-(2-methyl-1-oxo-1,2-dihydroisoquinolin-4-YL)urea",496286,LON-WEI-4d77710c-39,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496286,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),99000,,,,,
359,2012528,21363188,BindingDB,Cinnamoylcholine,234405,Cinnamoylcholine chloride (2),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234405,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606,Homo sapiens (human),,IC50 (nM),5.0e+4,PMID:21067438|DOI:10.3109/14756366.2010.529806,https://www.ncbi.nlm.nih.gov/pubmed/21067438|https://doi.org/10.3109/14756366.2010.529806,21067438,10.3109/14756366.2010.529806,
360,2012534,21781998,BindingDB,"Thieno[2,3-d]pyrimidine, 16",33228,"thieno[2,3-d]pyrimidine, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33228,1645,Heat shock protein HSP 90-beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1645,P08238,Heat shock protein HSP 90-beta,3326.0,HSP90AB1,9606,Homo sapiens (human),,IC50 (nM),1250000,PMID:19610616|DOI:10.1021/jm900357y,https://www.ncbi.nlm.nih.gov/pubmed/19610616|https://doi.org/10.1021/jm900357y,19610616,10.1021/jm900357y,
361,2035792,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [cadmium chloride results in increased phosphorylation of EIF4EBP1 protein],,,PMID:18021293,https://www.ncbi.nlm.nih.gov/pubmed/18021293,18021293,,
362,2035793,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [daunorubicin results in increased phosphorylation of EIF4EBP1 protein],,,PMID:21898527,https://www.ncbi.nlm.nih.gov/pubmed/21898527,21898527,,
363,2035794,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [[[sodium arsenite results in increased abundance of arsenic] which co-treated with benzo(a)pyrene] results in increased phosphorylation of EIF4EBP1 protein],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,
364,2035795,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein],,,PMID:33609687,https://www.ncbi.nlm.nih.gov/pubmed/33609687,33609687,,
365,2012529,21960798,BindingDB,"(4-Hydroxy-3-methoxyphenyl)-(2,3,4-trihydroxyphenyl)methanone",234393,"Polyhydroxy benzophenone, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234393,9974,Polyphenol oxidase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9974,Q00024,Polyphenol oxidase 1,,,5341,Agaricus bisporus,,IC50 (nM),6.4e+3,PMID:20939763|DOI:10.3109/14756366.2010.521745,https://www.ncbi.nlm.nih.gov/pubmed/20939763|https://doi.org/10.3109/14756366.2010.521745,20939763,10.3109/14756366.2010.521745,
366,2012527,22049997,Drug Gene Interaction database (DGIdb),"3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide",,PH-797804,https://www.dgidb.org/drugs/drugbank:DB07941,,MAPK13,https://www.dgidb.org/genes/hgnc:6875,,,5603.0,MAPK13,9606,Homo sapiens (human),,,,,,,,
367,2012530,22132666,Therapeutic Target Database (TTD),"6,7-Dimethoxy-4-(3-methoxyphenoxy)quinoline",D09QTC,"6,7-Dimethoxy-4-(3-methoxy-phenoxy)-quinoline",https://idrblab.net/ttd/data/drug/details/D09QTC,T59102,Platelet-derived growth factor receptor beta (PDGFRB),https://idrblab.net/ttd/data/target/details/T59102,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606,Homo sapiens (human),Inhibitor,,,,,,,
368,2012535,22184193,BindingDB,"(2-Hydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone",234397,"Polyhydroxy benzophenone, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234397,9974,Polyphenol oxidase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9974,Q00024,Polyphenol oxidase 1,,,5341,Agaricus bisporus,,IC50 (nM),8.8e+3,PMID:20939763|DOI:10.3109/14756366.2010.521745,https://www.ncbi.nlm.nih.gov/pubmed/20939763|https://doi.org/10.3109/14756366.2010.521745,20939763,10.3109/14756366.2010.521745,
369,2012531,22227467,Drug Gene Interaction database (DGIdb),Divalproex sodium [vandf],,DIVALPROEX SODIUM,https://www.dgidb.org/drugs/rxcui:266856,,ABAT,https://www.dgidb.org/genes/hgnc:23,,,18.0,ABAT,9606,Homo sapiens (human),,,,,,,,
370,2012532,22227467,Drug Gene Interaction database (DGIdb),Divalproex sodium [vandf],,DIVALPROEX SODIUM,https://www.dgidb.org/drugs/rxcui:266856,,ABAT,https://www.dgidb.org/genes/hgnc:23,,,18.0,ABAT,9606,Homo sapiens (human),,,,,,,,
371,2012533,22291652,IUPHAR/BPS Guide to PHARMACOLOGY,"8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide",9398,PHA-408,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9398,2039,inhibitor of nuclear factor kappa B kinase subunit beta,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2039,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,3551.0,IKBKB,9606,Homo sapiens (human),Inhibition,pIC50,7.4,PMID:19168710,https://www.ncbi.nlm.nih.gov/pubmed/19168710,19168710,,
372,2012536,22316981,Therapeutic Target Database (TTD),1-(4-(methylsulfonyl)phenyl)-1H-pyrrole,D00TKO,1-(4-(methylsulfonyl)phenyl)-1H-pyrrole,https://idrblab.net/ttd/data/drug/details/D00TKO,T66665,Prostaglandin G/H synthase 2 (COX-2),https://idrblab.net/ttd/data/target/details/T66665,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),Inhibitor,,,,,,,
373,2012435,23646519,BindingDB,"2-{[2-(3-aminopiperidin-1-yl)-5,6-dimethyl-4,7-dioxo-1H,4H,5H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}benzonitrile",13805,"2-{[2-(3-aminopiperidin-1-yl)-5,6-dimethyl-4,7-dioxo-1H,4H,5H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}benzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13805,1264,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1264,P14740,Dipeptidyl peptidase 4,25253.0,Dpp4,10116,Rattus norvegicus (Norway rat),,Ki (nM),17,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
374,2012436,23646519,BindingDB,"2-{[2-(3-aminopiperidin-1-yl)-5,6-dimethyl-4,7-dioxo-1H,4H,5H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}benzonitrile",13805,"2-{[2-(3-aminopiperidin-1-yl)-5,6-dimethyl-4,7-dioxo-1H,4H,5H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}benzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13805,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606,Homo sapiens (human),,Ki (nM),>3000,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
375,2012437,23646520,BindingDB,"(2S)-N-[(1S)-1-carbamoyl-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-2-acetamido-3-phenylpropanamide",13807,"(2S)-N-[(1S)-1-carbamoyl-2-[4-(1,1,3-trioxo-1,2-thiazolidin-5-yl)phenyl]ethyl]-2-acetamido-3-phenylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13807,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606,Homo sapiens (human),,IC50 (nM),210,PMID:16916797|DOI:10.1074/jbc.M606873200,https://www.ncbi.nlm.nih.gov/pubmed/16916797|https://doi.org/10.1074/jbc.M606873200,16916797,10.1074/jbc.M606873200,
376,2012438,23646521,BindingDB,"(2S)-N-[(1S)-1-carbamoyl-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-3-phenyl-2-(phenylformamido)propanamide",13808,"(2S)-N-[(1S)-1-carbamoyl-2-[4-(1,1,3-trioxo-1,2-thiazolidin-5-yl)phenyl]ethyl]-3-phenyl-2-(phenylformamido)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13808,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606,Homo sapiens (human),,IC50 (nM),185,PMID:16916797|DOI:10.1074/jbc.M606873200,https://www.ncbi.nlm.nih.gov/pubmed/16916797|https://doi.org/10.1074/jbc.M606873200,16916797,10.1074/jbc.M606873200,
377,2012439,23646522,BindingDB,"({4-[(4E)-2-(1H-1,2,3-benzotriazol-1-yl)-2,5-diphenylpent-4-en-1-yl]phenyl}difluoromethyl)phosphonic acid",13815,"({4-[(4E)-2-(1H-1,2,3-benzotriazol-1-yl)-2,5-diphenylpent-4-en-1-yl]phenyl}difluoromethyl)phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13815,4970,Tyrosine-protein phosphatase non-receptor type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4970,P17706,Tyrosine-protein phosphatase non-receptor type 2,5771.0,PTPN2,9606,Homo sapiens (human),,IC50 (nM),95,PMID:16407290|DOI:10.1074/jbc.M511827200,https://www.ncbi.nlm.nih.gov/pubmed/16407290|https://doi.org/10.1074/jbc.M511827200,16407290,10.1074/jbc.M511827200,
378,2012440,23646522,BindingDB,"({4-[(4E)-2-(1H-1,2,3-benzotriazol-1-yl)-2,5-diphenylpent-4-en-1-yl]phenyl}difluoromethyl)phosphonic acid",13815,"({4-[(4E)-2-(1H-1,2,3-benzotriazol-1-yl)-2,5-diphenylpent-4-en-1-yl]phenyl}difluoromethyl)phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13815,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606,Homo sapiens (human),,IC50 (nM),109,PMID:16407290|DOI:10.1074/jbc.M511827200,https://www.ncbi.nlm.nih.gov/pubmed/16407290|https://doi.org/10.1074/jbc.M511827200,16407290,10.1074/jbc.M511827200,
379,2012459,23646523,BindingDB,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",13816,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13816,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606,Homo sapiens (human),,IC50 (nM),163,PMID:16407290|DOI:10.1074/jbc.M511827200,https://www.ncbi.nlm.nih.gov/pubmed/16407290|https://doi.org/10.1074/jbc.M511827200,16407290,10.1074/jbc.M511827200,
380,2012460,23646523,BindingDB,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",13816,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13816,4970,Tyrosine-protein phosphatase non-receptor type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4970,P17706,Tyrosine-protein phosphatase non-receptor type 2,5771.0,PTPN2,9606,Homo sapiens (human),,IC50 (nM),1600,PMID:16407290|DOI:10.1074/jbc.M511827200,https://www.ncbi.nlm.nih.gov/pubmed/16407290|https://doi.org/10.1074/jbc.M511827200,16407290,10.1074/jbc.M511827200,
381,2012461,23646523,BindingDB,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",13816,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13816,1413,Tyrosine-protein phosphatase non-receptor type 2 [V121L],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1413,P17706,Tyrosine-protein phosphatase non-receptor type 2,5771.0,PTPN2,9606,Homo sapiens (human),,IC50 (nM),138,PMID:16407290|DOI:10.1074/jbc.M511827200,https://www.ncbi.nlm.nih.gov/pubmed/16407290|https://doi.org/10.1074/jbc.M511827200,16407290,10.1074/jbc.M511827200,
382,2012462,23646523,BindingDB,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",13816,"[difluoro({4-[3-(4-fluorophenyl)-2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-3-oxo-2-[(2E)-3-phenylprop-2-en-1-yl]propyl]phenyl})methyl]phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13816,1412,Tyrosine-protein phosphatase non-receptor type 1 [L119V],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1412,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606,Homo sapiens (human),,IC50 (nM),1903,PMID:16407290|DOI:10.1074/jbc.M511827200,https://www.ncbi.nlm.nih.gov/pubmed/16407290|https://doi.org/10.1074/jbc.M511827200,16407290,10.1074/jbc.M511827200,
383,2012463,23649669,BindingDB,"Carbamic acid, N-(4-hydroxybutyl)-, 2-(5-((1S)-1-((2-amino-2-methyl-1-oxopropyl)amino)-2-(phenylmethoxy)ethyl)-1H-tetrazol-1-yl)ethyl ester",21941,"2-{5-[(1S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl]-1H-1,2,3,4-tetrazol-1-yl}ethyl N-(4-hydroxybutyl)carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21941,1991,Growth hormone secretagogue receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1991,Q92847,Growth hormone secretagogue receptor type 1,2693.0,GHSR,9606,Homo sapiens (human),,,,PMID:17973363|DOI:10.1021/jm7010595,https://www.ncbi.nlm.nih.gov/pubmed/17973363|https://doi.org/10.1021/jm7010595,17973363,10.1021/jm7010595,
384,2012516,23650961,Therapeutic Target Database (TTD),Toreforant,D04VBF,JNJ-38518168,https://idrblab.net/ttd/data/drug/details/D04VBF,T26500,Histamine H4 receptor (H4R),https://idrblab.net/ttd/data/target/details/T26500,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606,Homo sapiens (human),Antagonist,,,,,,,
385,2012517,23651551,Therapeutic Target Database (TTD),Leucomethylene Blue dihydrobromide,D5FSV8,TRx0237,https://idrblab.net/ttd/data/drug/details/D5FSV8,T45593,Microtubule-associated protein tau (MAPT),https://idrblab.net/ttd/data/target/details/T45593,P10636,Microtubule-associated protein tau,4137.0,MAPT,9606,Homo sapiens (human),Inhibitor,,,,,,,
386,2012389,23652731,DrugBank,Eliglustat,DB09039,Eliglustat,https://www.drugbank.ca/drugs/DB09039,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:25239269,https://www.ncbi.nlm.nih.gov/pubmed/25239269,25239269,,
387,2012390,23652731,DrugBank,Eliglustat,DB09039,Eliglustat,https://www.drugbank.ca/drugs/DB09039,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),Substrate,,,PMID:25239269,https://www.ncbi.nlm.nih.gov/pubmed/25239269,25239269,,
388,2012391,23652731,DrugBank,Eliglustat,DB09039,Eliglustat,https://www.drugbank.ca/drugs/DB09039,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:25239269,https://www.ncbi.nlm.nih.gov/pubmed/25239269,25239269,,
389,2012518,23652731,Drug Gene Interaction database (DGIdb),Eliglustat,,ELIGLUSTAT,https://www.dgidb.org/drugs/rxcui:1547220,,UGCG,https://www.dgidb.org/genes/hgnc:12524,,,7357.0,UGCG,9606,Homo sapiens (human),,,,,,,,
390,2012397,23653175,Therapeutic Target Database (TTD),Actb-1003,D0R6OM,ACTB-1003,https://idrblab.net/ttd/data/drug/details/D0R6OM,T47101,Fibroblast growth factor receptor 1 (FGFR1),https://idrblab.net/ttd/data/target/details/T47101,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606,Homo sapiens (human),Inhibitor,,,,,,,
391,2012398,23653507,DrugBank,(2s)-2-[3-(Aminomethyl)phenyl]-3-{(S)-Hydroxy[(1r)-2-Methyl-1-{[(2-Phenylethyl)sulfonyl]amino}propyl]phosphoryl}propanoic Acid,DB06835,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,https://www.drugbank.ca/drugs/DB06835,BE0003257,Carboxypeptidase B,https://www.drugbank.ca/bio_entities/BE0003257,P15086,Carboxypeptidase B,1360.0,CPB1,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
392,2012399,23653508,DrugBank,(2s)-2-[3-(Aminomethyl)phenyl]-3-[(R)-Hydroxy{(1r)-2-Methyl-1-[(Phenylsulfonyl)amino]propyl}phosphoryl]propanoic Acid,DB06921,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,https://www.drugbank.ca/drugs/DB06921,BE0003257,Carboxypeptidase B,https://www.drugbank.ca/bio_entities/BE0003257,P15086,Carboxypeptidase B,1360.0,CPB1,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
393,2012400,23653514,DrugBank,"N-[(2r)-5-(Aminosulfonyl)-2,3-Dihydro-1h-Inden-2-Yl]-2-Propylpentanamide",DB07048,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",https://www.drugbank.ca/drugs/DB07048,BE0000322,Carbonic anhydrase 2,https://www.drugbank.ca/bio_entities/BE0000322,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
394,2012519,23653540,Therapeutic Target Database (TTD),Enmetazobactam,D1MEH5,Enmetazobactam,https://idrblab.net/ttd/data/drug/details/D1MEH5,T38179,Staphylococcus Beta-lactamase (Stap-coc blaZ),https://idrblab.net/ttd/data/target/details/T38179,P00807,Beta-lactamase,79052806.0,,1280,Staphylococcus aureus,Inhibitor,,,,,,,
395,2012392,23653584,Drug Gene Interaction database (DGIdb),PRX-07034 hydrochloride,,PRX-07034,https://www.dgidb.org/drugs/drugbank:DB05993,,HTR6,https://www.dgidb.org/genes/hgnc:5301,,,3362.0,HTR6,9606,Homo sapiens (human),,,,,,,,
396,2012520,23653789,Therapeutic Target Database (TTD),Serlopitant,D0CB2B,Serlopitant,https://idrblab.net/ttd/data/drug/details/D0CB2B,T47094,Substance-P receptor (TACR1),https://idrblab.net/ttd/data/target/details/T47094,P25103,Substance-P receptor,6869.0,TACR1,9606,Homo sapiens (human),Antagonist,,,,,,,
397,2012401,23656759,Drug Gene Interaction database (DGIdb),iso-iantheran A,,ISO-IANTHERAN A,https://www.dgidb.org/drugs/chembl:CHEMBL240681,,P2RY1,https://www.dgidb.org/genes/hgnc:8539,,,5028.0,P2RY1,9606,Homo sapiens (human),,,,,,,,
398,2012393,23657350,BindingDB,"2-[(2-{3-[12-Methyl-8-(methylamino)-3-thia-1,7,10-triazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),4,7,9,11-pentaen-4-yl]phenyl}ethyl)amino]acetamide",25966,"2-[(2-{3-[12-methyl-8-(methylamino)-3-thia-1,7,10-triazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),4,7,9,11-pentaen-4-yl]phenyl}ethyl)amino]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25966,2933,Inhibitor of nuclear factor kappa-B kinase subunit beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2933,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,3551.0,IKBKB,9606,Homo sapiens (human),,IC50 (nM),13,PMID:17540562|DOI:10.1016/j.bmcl.2007.05.031,https://www.ncbi.nlm.nih.gov/pubmed/17540562|https://doi.org/10.1016/j.bmcl.2007.05.031,17540562,10.1016/j.bmcl.2007.05.031,
399,2012394,23657350,BindingDB,"2-[(2-{3-[12-Methyl-8-(methylamino)-3-thia-1,7,10-triazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),4,7,9,11-pentaen-4-yl]phenyl}ethyl)amino]acetamide",25966,"2-[(2-{3-[12-methyl-8-(methylamino)-3-thia-1,7,10-triazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),4,7,9,11-pentaen-4-yl]phenyl}ethyl)amino]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25966,50005048,Inhibitor of nuclear factor kappa-B kinase subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50005048,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,1147.0,CHUK,9606,Homo sapiens (human),,IC50 (nM),390,PMID:17540562|DOI:10.1016/j.bmcl.2007.05.031,https://www.ncbi.nlm.nih.gov/pubmed/17540562|https://doi.org/10.1016/j.bmcl.2007.05.031,17540562,10.1016/j.bmcl.2007.05.031,
400,2012395,23657507,BindingDB,3-[[4-(5-Hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide,26166,"2,4-dianilino pyrimidine, 23",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26166,50000539,Proto-oncogene tyrosine-protein kinase LCK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50000539,P06240,Proto-oncogene tyrosine-protein kinase LCK ,16818.0,Lck,10090,Mus musculus (house mouse),,IC50 (nM),8.5,PMID:17600705|DOI:10.1016/j.bmcl.2007.04.029,https://www.ncbi.nlm.nih.gov/pubmed/17600705|https://doi.org/10.1016/j.bmcl.2007.04.029,17600705,10.1016/j.bmcl.2007.04.029,
401,2012464,23657507,Therapeutic Target Database (TTD),3-[[4-(5-Hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide,D04TLI,PMID17600705C23,https://idrblab.net/ttd/data/drug/details/D04TLI,T32590,Tyrosine-protein kinase TXK (TXK),https://idrblab.net/ttd/data/target/details/T32590,P42681,Tyrosine-protein kinase TXK,7294.0,TXK,9606,Homo sapiens (human),Inhibitor,,,,,,,
402,2012489,23657507,Therapeutic Target Database (TTD),3-[[4-(5-Hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide,D04TLI,PMID17600705C23,https://idrblab.net/ttd/data/drug/details/D04TLI,T62431,Tyrosine-protein kinase SYK (SYK),https://idrblab.net/ttd/data/target/details/T62431,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606,Homo sapiens (human),Inhibitor,,,,,,,
403,2012490,23657507,Therapeutic Target Database (TTD),3-[[4-(5-Hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide,D04TLI,PMID17600705C23,https://idrblab.net/ttd/data/drug/details/D04TLI,T68163,Tyrosine-protein kinase Lyn (JTK8),https://idrblab.net/ttd/data/target/details/T68163,P07948,Tyrosine-protein kinase Lyn,4067.0,LYN,9606,Homo sapiens (human),Inhibitor,,,,,,,
404,2012491,23657507,Therapeutic Target Database (TTD),3-[[4-(5-Hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide,D04TLI,PMID17600705C23,https://idrblab.net/ttd/data/drug/details/D04TLI,T12499,LCK tyrosine protein kinase (LCK),https://idrblab.net/ttd/data/target/details/T12499,P06239,Tyrosine-protein kinase Lck,3932.0,LCK,9606,Homo sapiens (human),Inhibitor,,,,,,,
405,2012396,23657635,BindingDB,"Benzamide, 3-[[4-[(5-methyl-1H-indazol-4-yl)amino]-2-pyrimidinyl]amino]-",26180,"2,4-dianilino pyrimidine, 37",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26180,50000539,Proto-oncogene tyrosine-protein kinase LCK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50000539,P06240,Proto-oncogene tyrosine-protein kinase LCK ,16818.0,Lck,10090,Mus musculus (house mouse),,IC50 (nM),12,PMID:17600705|DOI:10.1016/j.bmcl.2007.04.029,https://www.ncbi.nlm.nih.gov/pubmed/17600705|https://doi.org/10.1016/j.bmcl.2007.04.029,17600705,10.1016/j.bmcl.2007.04.029,
406,2012492,23657864,Therapeutic Target Database (TTD),"N,N'-(hexane-1,6-diyl)bis(1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-L-prolyl-beta-phenyl-L-phenylalaninamide)",D0O4UQ,BV-6,https://idrblab.net/ttd/data/drug/details/D0O4UQ,T84780,Cellular inhibitor of apoptosis 1 (BIRC2),https://idrblab.net/ttd/data/target/details/T84780,Q13490,Baculoviral IAP repeat-containing protein 2,329.0,BIRC2,9606,Homo sapiens (human),Inhibitor,,,,,,,
407,2012493,23657864,Therapeutic Target Database (TTD),"N,N'-(hexane-1,6-diyl)bis(1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-L-prolyl-beta-phenyl-L-phenylalaninamide)",D0O4UQ,BV-6,https://idrblab.net/ttd/data/drug/details/D0O4UQ,T81892,XIAP messenger RNA (XIAP mRNA),https://idrblab.net/ttd/data/target/details/T81892,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606,Homo sapiens (human),Inhibitor,,,,,,,
408,2012494,23658607,Drug Gene Interaction database (DGIdb),Remimazolam Besylate,,REMIMAZOLAM BESYLATE,https://www.dgidb.org/drugs/rxcui:2383942,,GABRG3,https://www.dgidb.org/genes/hgnc:4088,,,2567.0,GABRG3,9606,Homo sapiens (human),Positive modulator,,,,,,,
409,2012521,23661566,BindingDB,"2-[(4-methyl-1-oxo-2,3,4,9-tetrahydropyrido[3,4-b]indole-6-carbonyl)amino]-N-(1-methylpiperidin-4-yl)-1,3-thiazole-4-carboxamide",30273,"carboline analog, 85",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30273,3676,MAP kinase-activated protein kinase 2 [41-364],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3676,P49137,MAP kinase-activated protein kinase 2,9261.0,MAPKAPK2,9606,Homo sapiens (human),,IC50 (nM),10,PMID:17576063|DOI:10.1016/j.bmcl.2007.05.101,https://www.ncbi.nlm.nih.gov/pubmed/17576063|https://doi.org/10.1016/j.bmcl.2007.05.101,17576063,10.1016/j.bmcl.2007.05.101,
410,2012402,23661666,Therapeutic Target Database (TTD),3-(((3-(4-((Methylsulfonyl)amino)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid,D0W4WP,CVT-10216,https://idrblab.net/ttd/data/drug/details/D0W4WP,T44282,Mitochondrial aldehyde dehydrogenase (ALDH2),https://idrblab.net/ttd/data/target/details/T44282,P05091,"Aldehyde dehydrogenase, mitochondrial",217.0,ALDH2,9606,Homo sapiens (human),Antagonist,,,,,,,
411,2012522,23661666,Comparative Toxicogenomics Database (CTD),3-(((3-(4-((Methylsulfonyl)amino)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid,C550386,CVT-10216,https://ctdbase.org/detail.go?type=chem&acc=C550386,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10116,Rattus norvegicus (Norway rat),CVT-10216 results in decreased activity of ALDH2 protein|[cvt-10216 results in decreased activity of ALDH2 protein] which results in increased abundance of tetrahydropapaveroline|[[cvt-10216 results in decreased activity of ALDH2 protein] which results in increased abundance of tetrahydropapaveroline] inhibits the reaction [cocaine results in increased abundance of and results in increased secretion of dopamine],,,PMID:20729865,https://www.ncbi.nlm.nih.gov/pubmed/20729865,20729865,,
412,2012403,23663400,ChEMBL,Tazobactam sodium,CHEMBL1439,TAZOBACTAM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1439/,CHEMBL2364670,Bacterial beta-lactamase TEM,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364670/,P62593,Beta-lactamase TEM,84568456.0,,2,Bacteria (eubacteria),Bacterial beta-lactamase TEM inhibitor,,,PMID:10511459,https://www.ncbi.nlm.nih.gov/pubmed/10511459,10511459,,
413,2012404,23663414,Therapeutic Target Database (TTD),Olpadronic acid sodium salt,D0OJ5M,OLPADRONIC ACID SODIUM SALT,https://idrblab.net/ttd/data/drug/details/D0OJ5M,T86528,Geranyltranstransferase (FDPS),https://idrblab.net/ttd/data/target/details/T86528,P14324,Farnesyl pyrophosphate synthase,2224.0,FDPS,9606,Homo sapiens (human),Modulator,,,,,,,
414,2012495,23663537,ChEMBL,Theophylline Sodium Glycinate,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200578/,CHEMBL2094125,Phosphodiesterase 3,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094125/,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",5140.0,PDE3B,9606,Homo sapiens (human),Phosphodiesterase 3 inhibitor,,,,,,,
415,2012496,23663537,ChEMBL,Theophylline Sodium Glycinate,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200578/,CHEMBL2094125,Phosphodiesterase 3,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094125/,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",5139.0,PDE3A,9606,Homo sapiens (human),Phosphodiesterase 3 inhibitor,,,,,,,
416,2012497,23663537,ChEMBL,Theophylline Sodium Glycinate,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200578/,CHEMBL2111329,Adenosine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111329/,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606,Homo sapiens (human),Adenosine receptor antagonist,,,PMID:3588607|PMID:12954362|PMID:14992338|PMID:15980878,https://www.ncbi.nlm.nih.gov/pubmed/3588607|https://www.ncbi.nlm.nih.gov/pubmed/12954362|https://www.ncbi.nlm.nih.gov/pubmed/14992338|https://www.ncbi.nlm.nih.gov/pubmed/15980878,3588607|12954362|14992338|15980878,,
417,2012498,23663537,ChEMBL,Theophylline Sodium Glycinate,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200578/,CHEMBL2111329,Adenosine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111329/,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606,Homo sapiens (human),Adenosine receptor antagonist,,,PMID:3588607|PMID:12954362|PMID:14992338|PMID:15980878,https://www.ncbi.nlm.nih.gov/pubmed/3588607|https://www.ncbi.nlm.nih.gov/pubmed/12954362|https://www.ncbi.nlm.nih.gov/pubmed/14992338|https://www.ncbi.nlm.nih.gov/pubmed/15980878,3588607|12954362|14992338|15980878,,
418,2012537,23663537,ChEMBL,Theophylline Sodium Glycinate,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200578/,CHEMBL2111329,Adenosine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111329/,P29275,Adenosine receptor A2b,136.0,ADORA2B,9606,Homo sapiens (human),Adenosine receptor antagonist,,,PMID:3588607|PMID:12954362|PMID:14992338|PMID:15980878,https://www.ncbi.nlm.nih.gov/pubmed/3588607|https://www.ncbi.nlm.nih.gov/pubmed/12954362|https://www.ncbi.nlm.nih.gov/pubmed/14992338|https://www.ncbi.nlm.nih.gov/pubmed/15980878,3588607|12954362|14992338|15980878,,
419,2012538,23663537,ChEMBL,Theophylline Sodium Glycinate,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200578/,CHEMBL2111329,Adenosine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111329/,P30542,Adenosine receptor A1,134.0,ADORA1,9606,Homo sapiens (human),Adenosine receptor antagonist,,,PMID:3588607|PMID:12954362|PMID:14992338|PMID:15980878,https://www.ncbi.nlm.nih.gov/pubmed/3588607|https://www.ncbi.nlm.nih.gov/pubmed/12954362|https://www.ncbi.nlm.nih.gov/pubmed/14992338|https://www.ncbi.nlm.nih.gov/pubmed/15980878,3588607|12954362|14992338|15980878,,
420,2012539,23663870,ChEMBL,Sodium Oxybate,CHEMBL1200682,SODIUM OXYBATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200682/,CHEMBL2111463,GABA-B receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111463/,O75899,Gamma-aminobutyric acid type B receptor subunit 2,9568.0,GABBR2,9606,Homo sapiens (human),GABA-B receptor agonist,,,PMID:23065655,https://www.ncbi.nlm.nih.gov/pubmed/23065655,23065655,,
421,2012540,23663870,ChEMBL,Sodium Oxybate,CHEMBL1200682,SODIUM OXYBATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200682/,CHEMBL2111463,GABA-B receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2111463/,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,2550.0,GABBR1,9606,Homo sapiens (human),GABA-B receptor agonist,,,PMID:23065655,https://www.ncbi.nlm.nih.gov/pubmed/23065655,23065655,,
422,2012405,23663938,ChEMBL,Ceftizoxime Sodium,CHEMBL1201019,CEFTIZOXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7018389|PMID:15716453,https://www.ncbi.nlm.nih.gov/pubmed/7018389|https://www.ncbi.nlm.nih.gov/pubmed/15716453,7018389|15716453,,
423,2012406,23663938,ChEMBL,Ceftizoxime Sodium,CHEMBL1201019,CEFTIZOXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7018389|PMID:15716453,https://www.ncbi.nlm.nih.gov/pubmed/7018389|https://www.ncbi.nlm.nih.gov/pubmed/15716453,7018389|15716453,,
424,2012426,23663938,ChEMBL,Ceftizoxime Sodium,CHEMBL1201019,CEFTIZOXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7018389|PMID:15716453,https://www.ncbi.nlm.nih.gov/pubmed/7018389|https://www.ncbi.nlm.nih.gov/pubmed/15716453,7018389|15716453,,
425,2012427,23663938,ChEMBL,Ceftizoxime Sodium,CHEMBL1201019,CEFTIZOXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7018389|PMID:15716453,https://www.ncbi.nlm.nih.gov/pubmed/7018389|https://www.ncbi.nlm.nih.gov/pubmed/15716453,7018389|15716453,,
426,2012428,23663938,ChEMBL,Ceftizoxime Sodium,CHEMBL1201019,CEFTIZOXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7018389|PMID:15716453,https://www.ncbi.nlm.nih.gov/pubmed/7018389|https://www.ncbi.nlm.nih.gov/pubmed/15716453,7018389|15716453,,
427,2012429,23663938,ChEMBL,Ceftizoxime Sodium,CHEMBL1201019,CEFTIZOXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7018389|PMID:15716453,https://www.ncbi.nlm.nih.gov/pubmed/7018389|https://www.ncbi.nlm.nih.gov/pubmed/15716453,7018389|15716453,,
428,2012430,23663938,ChEMBL,Ceftizoxime Sodium,CHEMBL1201019,CEFTIZOXIME SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7018389|PMID:15716453,https://www.ncbi.nlm.nih.gov/pubmed/7018389|https://www.ncbi.nlm.nih.gov/pubmed/15716453,7018389|15716453,,
429,2012541,23663938,Comparative Toxicogenomics Database (CTD),Ceftizoxime Sodium,D015296,Ceftizoxime,https://ctdbase.org/detail.go?type=chem&acc=D015296,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606,Homo sapiens (human),Ceftizoxime results in decreased activity of DHFR protein,,,PMID:25418905,https://www.ncbi.nlm.nih.gov/pubmed/25418905,25418905,,
430,2012542,23663938,Comparative Toxicogenomics Database (CTD),Ceftizoxime Sodium,D015296,Ceftizoxime,https://ctdbase.org/detail.go?type=chem&acc=D015296,9356,SLC22A6,https://ctdbase.org/detail.go?type=gene&acc=9356,,,9356.0,SLC22A6,9606,Homo sapiens (human),Ceftizoxime inhibits the reaction [SLC22A6 protein results in increased uptake of p-aminohippuric acid]|slc22a6 protein results in increased uptake of ceftizoxime,,,PMID:16098483,https://www.ncbi.nlm.nih.gov/pubmed/16098483,16098483,,
431,2012543,23663938,Comparative Toxicogenomics Database (CTD),Ceftizoxime Sodium,D015296,Ceftizoxime,https://ctdbase.org/detail.go?type=chem&acc=D015296,9376,SLC22A8,https://ctdbase.org/detail.go?type=gene&acc=9376,,,9376.0,SLC22A8,9606,Homo sapiens (human),SLC22A8 protein results in increased uptake of ceftizoxime|ceftizoxime inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate],,,PMID:16098483,https://www.ncbi.nlm.nih.gov/pubmed/16098483,16098483,,
432,2012431,23663954,Comparative Toxicogenomics Database (CTD),Furegrelate sodium,C039936,furegrelate,https://ctdbase.org/detail.go?type=chem&acc=C039936,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Furegrelate inhibits the reaction [doxorubicin results in increased secretion of IL1B protein],,,PMID:8132220,https://www.ncbi.nlm.nih.gov/pubmed/8132220,8132220,,
433,2012432,23663954,Comparative Toxicogenomics Database (CTD),Furegrelate sodium,C039936,furegrelate,https://ctdbase.org/detail.go?type=chem&acc=C039936,6916,TBXAS1,https://ctdbase.org/detail.go?type=gene&acc=6916,,,6916.0,TBXAS1,9606,Homo sapiens (human),Furegrelate results in decreased activity of TBXAS1 protein,,,PMID:17562850,https://www.ncbi.nlm.nih.gov/pubmed/17562850,17562850,,
434,2012523,23663959,Drug Gene Interaction database (DGIdb),Meclofenamate Sodium,,MECLOFENAMATE SODIUM,https://www.dgidb.org/drugs/rxcui:6677,,PTGS1,https://www.dgidb.org/genes/hgnc:9604,,,5742.0,PTGS1,9606,Homo sapiens (human),Inhibitor,,,,,,,
435,2012544,23663959,ChEMBL,Meclofenamate Sodium,CHEMBL1562610,MECLOFENAMATE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1562610/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),Cyclooxygenase inhibitor,,,PMID:3020588,https://www.ncbi.nlm.nih.gov/pubmed/3020588,3020588,,
436,2012545,23663959,ChEMBL,Meclofenamate Sodium,CHEMBL1562610,MECLOFENAMATE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1562610/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),Cyclooxygenase inhibitor,,,PMID:3020588,https://www.ncbi.nlm.nih.gov/pubmed/3020588,3020588,,
437,2012596,23663959,Drug Gene Interaction database (DGIdb),Meclofenamate Sodium,,MECLOFENAMATE SODIUM,https://www.dgidb.org/drugs/rxcui:6677,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606,Homo sapiens (human),,,,,,,,
438,2012433,23663969,ChEMBL,Cefpiramide Sodium,CHEMBL1200672,CEFPIRAMIDE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200672/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3943292|PMID:6426381|PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/3943292|https://www.ncbi.nlm.nih.gov/pubmed/6426381|https://www.ncbi.nlm.nih.gov/pubmed/6448021,3943292|6426381|6448021,,
439,2012434,23663969,ChEMBL,Cefpiramide Sodium,CHEMBL1200672,CEFPIRAMIDE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200672/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3943292|PMID:6426381|PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/3943292|https://www.ncbi.nlm.nih.gov/pubmed/6426381|https://www.ncbi.nlm.nih.gov/pubmed/6448021,3943292|6426381|6448021,,
440,2012441,23663969,ChEMBL,Cefpiramide Sodium,CHEMBL1200672,CEFPIRAMIDE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200672/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3943292|PMID:6426381|PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/3943292|https://www.ncbi.nlm.nih.gov/pubmed/6426381|https://www.ncbi.nlm.nih.gov/pubmed/6448021,3943292|6426381|6448021,,
441,2012442,23663969,ChEMBL,Cefpiramide Sodium,CHEMBL1200672,CEFPIRAMIDE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200672/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3943292|PMID:6426381|PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/3943292|https://www.ncbi.nlm.nih.gov/pubmed/6426381|https://www.ncbi.nlm.nih.gov/pubmed/6448021,3943292|6426381|6448021,,
442,2012443,23663969,ChEMBL,Cefpiramide Sodium,CHEMBL1200672,CEFPIRAMIDE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200672/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3943292|PMID:6426381|PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/3943292|https://www.ncbi.nlm.nih.gov/pubmed/6426381|https://www.ncbi.nlm.nih.gov/pubmed/6448021,3943292|6426381|6448021,,
443,2012444,23663969,ChEMBL,Cefpiramide Sodium,CHEMBL1200672,CEFPIRAMIDE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200672/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3943292|PMID:6426381|PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/3943292|https://www.ncbi.nlm.nih.gov/pubmed/6426381|https://www.ncbi.nlm.nih.gov/pubmed/6448021,3943292|6426381|6448021,,
444,2012445,23663969,ChEMBL,Cefpiramide Sodium,CHEMBL1200672,CEFPIRAMIDE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200672/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3943292|PMID:6426381|PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/3943292|https://www.ncbi.nlm.nih.gov/pubmed/6426381|https://www.ncbi.nlm.nih.gov/pubmed/6448021,3943292|6426381|6448021,,
445,2012446,23663973,ChEMBL,Sulbactam Sodium,CHEMBL1200944,SULBACTAM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200944/,CHEMBL2364670,Bacterial beta-lactamase TEM,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364670/,P62593,Beta-lactamase TEM,84568456.0,,2,Bacteria (eubacteria),Bacterial beta-lactamase TEM inhibitor,,,,,,,
446,2012447,23663974,ChEMBL,Cefoperazone Sodium,CHEMBL1200482,CEFOPERAZONE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200482/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/6448021,6448021,,
447,2012448,23663974,ChEMBL,Cefoperazone Sodium,CHEMBL1200482,CEFOPERAZONE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200482/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/6448021,6448021,,
448,2012449,23663974,ChEMBL,Cefoperazone Sodium,CHEMBL1200482,CEFOPERAZONE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200482/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/6448021,6448021,,
449,2012450,23663974,ChEMBL,Cefoperazone Sodium,CHEMBL1200482,CEFOPERAZONE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200482/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/6448021,6448021,,
450,2012451,23663974,ChEMBL,Cefoperazone Sodium,CHEMBL1200482,CEFOPERAZONE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200482/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/6448021,6448021,,
451,2012452,23663974,ChEMBL,Cefoperazone Sodium,CHEMBL1200482,CEFOPERAZONE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200482/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/6448021,6448021,,
452,2012453,23663974,ChEMBL,Cefoperazone Sodium,CHEMBL1200482,CEFOPERAZONE SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200482/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:6448021,https://www.ncbi.nlm.nih.gov/pubmed/6448021,6448021,,
453,2012597,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,335625,ADCYAP1B,https://ctdbase.org/detail.go?type=gene&acc=335625,,,335625.0,adcyap1b,7955,Danio rerio (zebrafish),Cefoperazone results in decreased expression of ADCYAP1B mrna|cefoperazone metabolite results in decreased expression of ADCYAP1B mRNA,,,PMID:28465218,https://www.ncbi.nlm.nih.gov/pubmed/28465218,28465218,,
454,2012598,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,786,CACNG1,https://ctdbase.org/detail.go?type=gene&acc=786,,,786.0,CACNG1,7955,Danio rerio (zebrafish),Cefoperazone metabolite results in decreased expression of CACNG1 mrna|cefoperazone results in decreased expression of CACNG1 mRNA,,,PMID:28465218,https://www.ncbi.nlm.nih.gov/pubmed/28465218,28465218,,
455,2012599,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,56853,CELF4,https://ctdbase.org/detail.go?type=gene&acc=56853,,,56853.0,CELF4,7955,Danio rerio (zebrafish),Cefoperazone results in decreased expression of CELF4 mrna|cefoperazone metabolite results in decreased expression of CELF4 mRNA,,,PMID:28465218,https://www.ncbi.nlm.nih.gov/pubmed/28465218,28465218,,
456,2012600,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,555472,CNNM2A,https://ctdbase.org/detail.go?type=gene&acc=555472,,,555472.0,cnnm2a,7955,Danio rerio (zebrafish),Cefoperazone results in increased expression of CNNM2A mRNA,,,PMID:29689360,https://www.ncbi.nlm.nih.gov/pubmed/29689360,29689360,,
457,2012601,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,792063,FT2,https://ctdbase.org/detail.go?type=gene&acc=792063,,,792063.0,ft2,7955,Danio rerio (zebrafish),Cefoperazone results in decreased expression of FT2 mrna|cefoperazone metabolite results in decreased expression of FT2 mRNA,,,PMID:28465218,https://www.ncbi.nlm.nih.gov/pubmed/28465218,28465218,,
458,2012602,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,3036,HAS1,https://ctdbase.org/detail.go?type=gene&acc=3036,,,3036.0,HAS1,7955,Danio rerio (zebrafish),Cefoperazone metabolite results in decreased expression of HAS1 mRNA,,,PMID:28465218,https://www.ncbi.nlm.nih.gov/pubmed/28465218,28465218,,
459,2012603,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,3036,HAS1,https://ctdbase.org/detail.go?type=gene&acc=3036,,,3036.0,HAS1,7955,Danio rerio (zebrafish),Cefoperazone results in decreased expression of HAS1 mRNA,,,PMID:28465218|PMID:29689360,https://www.ncbi.nlm.nih.gov/pubmed/28465218|https://www.ncbi.nlm.nih.gov/pubmed/29689360,28465218|29689360,,
460,2012604,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,3486,IGFBP3,https://ctdbase.org/detail.go?type=gene&acc=3486,,,3486.0,IGFBP3,7955,Danio rerio (zebrafish),Cefoperazone results in decreased expression of IGFBP3 mrna|cefoperazone metabolite results in decreased expression of IGFBP3 mRNA,,,PMID:28465218,https://www.ncbi.nlm.nih.gov/pubmed/28465218,28465218,,
461,2012605,23663974,Comparative Toxicogenomics Database (CTD),Cefoperazone Sodium,D002438,Cefoperazone,https://ctdbase.org/detail.go?type=chem&acc=D002438,556537,NRCAMA,https://ctdbase.org/detail.go?type=gene&acc=556537,,,556537.0,nrcama,7955,Danio rerio (zebrafish),Cefoperazone metabolite results in decreased expression of NRCAMA mrna|cefoperazone results in decreased expression of NRCAMA mRNA,,,PMID:28465218,https://www.ncbi.nlm.nih.gov/pubmed/28465218,28465218,,
462,2012454,23663979,ChEMBL,Ampicillin Sodium,CHEMBL1200758,AMPICILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200758/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7447421,https://www.ncbi.nlm.nih.gov/pubmed/7447421,7447421,,
463,2012455,23663979,ChEMBL,Ampicillin Sodium,CHEMBL1200758,AMPICILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200758/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7447421,https://www.ncbi.nlm.nih.gov/pubmed/7447421,7447421,,
464,2012456,23663979,ChEMBL,Ampicillin Sodium,CHEMBL1200758,AMPICILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200758/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7447421,https://www.ncbi.nlm.nih.gov/pubmed/7447421,7447421,,
465,2012457,23663979,ChEMBL,Ampicillin Sodium,CHEMBL1200758,AMPICILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200758/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7447421,https://www.ncbi.nlm.nih.gov/pubmed/7447421,7447421,,
466,2012458,23663979,ChEMBL,Ampicillin Sodium,CHEMBL1200758,AMPICILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200758/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7447421,https://www.ncbi.nlm.nih.gov/pubmed/7447421,7447421,,
467,2012481,23663979,ChEMBL,Ampicillin Sodium,CHEMBL1200758,AMPICILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200758/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7447421,https://www.ncbi.nlm.nih.gov/pubmed/7447421,7447421,,
468,2012482,23663979,ChEMBL,Ampicillin Sodium,CHEMBL1200758,AMPICILLIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200758/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:7447421,https://www.ncbi.nlm.nih.gov/pubmed/7447421,7447421,,
469,2012524,23663985,Therapeutic Target Database (TTD),Sivelestat sodium,D05QHL,Sivelestat sodium hydrate,https://idrblab.net/ttd/data/drug/details/D05QHL,T40332,Neutrophil elastase (NE),https://idrblab.net/ttd/data/target/details/T40332,P08246,Neutrophil elastase,1991.0,ELANE,9606,Homo sapiens (human),Inhibitor,,,,,,,
470,2012483,23663990,Comparative Toxicogenomics Database (CTD),Iralukast sodium,C067425,iralukast,https://ctdbase.org/detail.go?type=chem&acc=C067425,10800,CYSLTR1,https://ctdbase.org/detail.go?type=gene&acc=10800,,,10800.0,CYSLTR1,9606,Homo sapiens (human),Iralukast binds to CYSLTR1 protein|iralukast inhibits the reaction [leukotriene D4 binds to CYSLTR1 protein],,,PMID:10825389,https://www.ncbi.nlm.nih.gov/pubmed/10825389,10825389,,
471,2012525,23663994,Therapeutic Target Database (TTD),Ifetroban sodium,D0B2WK,Ifetroban sodium,https://idrblab.net/ttd/data/drug/details/D0B2WK,T76198,Thromboxane A2 receptor (TBXA2R),https://idrblab.net/ttd/data/target/details/T76198,P21731,Thromboxane A2 receptor ,6915.0,TBXA2R,9606,Homo sapiens (human),Antagonist,,,,,,,
472,2012654,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CYP3A5,https://www.dgidb.org/genes/hgnc:2638,,,1577.0,CYP3A5,9606,Homo sapiens (human),,,,,,,,
473,2012655,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,LTC4S,https://www.dgidb.org/genes/hgnc:6719,,,4056.0,LTC4S,9606,Homo sapiens (human),,,,,,,,
474,2012656,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,UGT1A3,https://www.dgidb.org/genes/hgnc:12535,,,54659.0,UGT1A3,9606,Homo sapiens (human),,,,,,,,
475,2012484,23664709,ChEMBL,Penicillin G Potassium,CHEMBL1223,PENICILLIN G POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1223/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
476,2012485,23664709,ChEMBL,Penicillin G Potassium,CHEMBL1223,PENICILLIN G POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1223/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
477,2012486,23664709,ChEMBL,Penicillin G Potassium,CHEMBL1223,PENICILLIN G POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1223/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
478,2012487,23664709,ChEMBL,Penicillin G Potassium,CHEMBL1223,PENICILLIN G POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1223/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
479,2012488,23664709,ChEMBL,Penicillin G Potassium,CHEMBL1223,PENICILLIN G POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1223/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
480,2012499,23664709,ChEMBL,Penicillin G Potassium,CHEMBL1223,PENICILLIN G POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1223/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
481,2012500,23664709,ChEMBL,Penicillin G Potassium,CHEMBL1223,PENICILLIN G POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1223/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:3245263|PMID:11353613|PMID:19528266,https://www.ncbi.nlm.nih.gov/pubmed/3245263|https://www.ncbi.nlm.nih.gov/pubmed/11353613|https://www.ncbi.nlm.nih.gov/pubmed/19528266,3245263|11353613|19528266,,
482,2012657,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0005077,"Actin, alpha cardiac muscle 1",http://www.t3db.ca/biodb/bio_entities/BE0005077,P68032,"Actin, alpha cardiac muscle 1",70.0,ACTC1,9606,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
483,2012658,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0002101,"Actin, alpha skeletal muscle",http://www.t3db.ca/biodb/bio_entities/BE0002101,P68133,"Actin, alpha skeletal muscle",58.0,ACTA1,9606,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
484,2012659,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0005076,"Actin, aortic smooth muscle",http://www.t3db.ca/biodb/bio_entities/BE0005076,P62736,"Actin, aortic smooth muscle",59.0,ACTA2,9606,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
485,2012660,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0004966,"Actin, cytoplasmic 1",http://www.t3db.ca/biodb/bio_entities/BE0004966,P60709,"Actin, cytoplasmic 1",60.0,ACTB,9606,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
486,2012661,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0005013,"Actin, cytoplasmic 2",http://www.t3db.ca/biodb/bio_entities/BE0005013,P63261,"Actin, cytoplasmic 2",71.0,ACTG1,9606,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
487,2012662,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0005078,"Actin, gamma-enteric smooth muscle",http://www.t3db.ca/biodb/bio_entities/BE0005078,P63267,"Actin, gamma-enteric smooth muscle",72.0,ACTG2,9606,Homo sapiens (human),Arsenic binds to actin. (A16),,,PMID:10221271,https://www.ncbi.nlm.nih.gov/pubmed/10221271,10221271,,
488,2012663,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0005051,DNA repair protein complementing XP-A cells,http://www.t3db.ca/biodb/bio_entities/BE0005051,P23025,DNA repair protein complementing XP-A cells,7507.0,XPA,9606,Homo sapiens (human),Arsenic binding of XPA is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
489,2012501,23665584,Drug Gene Interaction database (DGIdb),Mycophenolate Sodium,,MYCOPHENOLATE SODIUM,https://www.dgidb.org/drugs/rxcui:408142,,IMPDH2,https://www.dgidb.org/genes/hgnc:6053,,,3615.0,IMPDH2,9606,Homo sapiens (human),Inhibitor,,,,,,,
490,2012502,23665591,ChEMBL,Clavulanate Potassium,CHEMBL1003,CLAVULANATE POTASSIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1003/,CHEMBL2364670,Bacterial beta-lactamase TEM,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364670/,P62593,Beta-lactamase TEM,84568456.0,,2,Bacteria (eubacteria),Bacterial beta-lactamase TEM inhibitor,,,PMID:23612724,https://www.ncbi.nlm.nih.gov/pubmed/23612724,23612724,,
491,2012526,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,10116,Rattus norvegicus (Norway rat),Amoxicillin-potassium clavulanate combination results in increased secretion of CYCS protein,,,PMID:30273099,https://www.ncbi.nlm.nih.gov/pubmed/30273099,30273099,,
492,2012576,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Amoxicillin-potassium clavulanate combination results in increased activity of GPT protein,,,PMID:30273099,https://www.ncbi.nlm.nih.gov/pubmed/30273099,30273099,,
493,2012577,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in increased expression of GPX2 mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
494,2012578,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in increased expression of GSR mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
495,2012579,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,4199,ME1,https://ctdbase.org/detail.go?type=gene&acc=4199,,,4199.0,ME1,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in increased expression of ME1 mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
496,2012580,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,8431,NR0B2,https://ctdbase.org/detail.go?type=gene&acc=8431,,,8431.0,NR0B2,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in increased expression of NR0B2 mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
497,2012581,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in decreased expression of SLC10A1 mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
498,2012582,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,200931,SLC51A,https://ctdbase.org/detail.go?type=gene&acc=200931,,,200931.0,SLC51A,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in decreased expression of SLC51A mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
499,2012583,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657.0,SLC7A11,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in increased expression of SLC7A11 mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
500,2012584,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,7086,TKT,https://ctdbase.org/detail.go?type=gene&acc=7086,,,7086.0,TKT,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in increased expression of TKT mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
501,2012585,23665637,Comparative Toxicogenomics Database (CTD),Augmentin,D019980,Amoxicillin-Potassium Clavulanate Combination,https://ctdbase.org/detail.go?type=chem&acc=D019980,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606,Homo sapiens (human),Amoxicillin-potassium clavulanate combination results in increased expression of TXNRD1 mRNA,,,PMID:34767876,https://www.ncbi.nlm.nih.gov/pubmed/34767876,34767876,,
502,2012503,23665731,ChEMBL,Cefamandole Nafate,CHEMBL1618,CEFAMANDOLE NAFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1618/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02918,Penicillin-binding protein 1A,947907.0,mrcA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
503,2012504,23665731,ChEMBL,Cefamandole Nafate,CHEMBL1618,CEFAMANDOLE NAFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1618/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
504,2012505,23665731,ChEMBL,Cefamandole Nafate,CHEMBL1618,CEFAMANDOLE NAFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1618/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
505,2012506,23665731,ChEMBL,Cefamandole Nafate,CHEMBL1618,CEFAMANDOLE NAFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1618/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
506,2012507,23665731,ChEMBL,Cefamandole Nafate,CHEMBL1618,CEFAMANDOLE NAFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1618/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD68,"Peptidoglycan D,D-transpeptidase FtsI",75205004.0,mrdA,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
507,2012508,23665731,ChEMBL,Cefamandole Nafate,CHEMBL1618,CEFAMANDOLE NAFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1618/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
508,2012623,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,12655,CHIL3,https://ctdbase.org/detail.go?type=gene&acc=12655,,,12655.0,Chil3,10090,Mus musculus (house mouse),[rotenone co-treated with sodium bisulfite] results in increased expression of CHIL3 mRNA,,,PMID:25086357,https://www.ncbi.nlm.nih.gov/pubmed/25086357,25086357,,
509,2012624,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,4512,COX1,https://ctdbase.org/detail.go?type=gene&acc=4512,,,4512.0,COX1,10116,Rattus norvegicus (Norway rat),Sodium bisulfite results in decreased expression of COX1 mrna|acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of COX1 mrna],,,PMID:26980303,https://www.ncbi.nlm.nih.gov/pubmed/26980303,26980303,,
510,2012691,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Sodium bisulfite inhibits the reaction [rotenone results in increased expression of NOS2 mrna],,,PMID:25086357,https://www.ncbi.nlm.nih.gov/pubmed/25086357,25086357,,
511,2012692,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,10116,Rattus norvegicus (Norway rat),Sodium bisulfite results in decreased expression of NRF1 mrna|sodium bisulfite results in decreased expression of NRF1 protein|acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mrna],,,PMID:26980303,https://www.ncbi.nlm.nih.gov/pubmed/26980303,26980303,,
512,2012693,23665763,Comparative Toxicogenomics Database (CTD),Sodium Bisulfite,C009279,sodium bisulfite,https://ctdbase.org/detail.go?type=chem&acc=C009279,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10116,Rattus norvegicus (Norway rat),Sodium bisulfite results in decreased expression of PPARGC1A mrna|sodium bisulfite results in decreased expression of PPARGC1A protein|acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of PPARGC1A mrna],,,PMID:26980303,https://www.ncbi.nlm.nih.gov/pubmed/26980303,26980303,,
513,2012465,24811908,BindingDB,(2E)-3-{3-[6-(morpholin-4-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,28409,(2E)-3-{3-[6-(morpholin-4-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28409,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606,Homo sapiens (human),,IC50 (nM),1700,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
514,2012469,24812007,BindingDB,(2E)-3-{3-[6-(azepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,28405,(2E)-3-{3-[6-(azepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28405,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606,Homo sapiens (human),,IC50 (nM),3300,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
515,2012466,24812008,BindingDB,"(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]phenyl}prop-2-enoic acid",28398,"(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]phenyl}prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28398,20,Serine/threonine-protein kinase pim-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=20,P11309,Serine/threonine-protein kinase pim-1,5292.0,PIM1,9606,Homo sapiens (human),,IC50 (nM),50,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
516,2012467,24812008,BindingDB,"(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]phenyl}prop-2-enoic acid",28398,"(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]phenyl}prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28398,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606,Homo sapiens (human),,IC50 (nM),46,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
517,2012468,24812011,BindingDB,"(E)-3-{3-[6-(4-Methyl-[1,4]diazepan-1-yl)pyrazin-2-yl]-phenyl}-acrylic acid methyl ester",28399,"methyl (2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28399,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606,Homo sapiens (human),,IC50 (nM),>8000,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
518,2012470,24812117,BindingDB,"1-methyl-4-(6-{3-[(E)-2-(1H-1,2,3,4-tetrazol-5-yl)ethenyl]phenyl}pyrazin-2-yl)-1,4-diazepane",28402,"1-methyl-4-(6-{3-[(E)-2-(1H-1,2,3,4-tetrazol-5-yl)ethenyl]phenyl}pyrazin-2-yl)-1,4-diazepane",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28402,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606,Homo sapiens (human),,IC50 (nM),160,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
519,2012471,24812721,DrugBank,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",DB08557,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",https://www.drugbank.ca/drugs/DB08557,BE0001120,Heat shock protein HSP 90-alpha,https://www.drugbank.ca/bio_entities/BE0001120,P07900,Heat shock protein HSP 90-alpha,3320.0,HSP90AA1,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
520,2035781,25190627,BindingDB,"3-[2-(Butylamino)ethyl]-8-(7-chloro-1,2,3,4-tetrahydronaphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",26952,"3-[2-(butylamino)ethyl]-8-(7-chloro-1,2,3,4-tetrahydronaphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26952,2212,Kappa-type opioid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2212,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,Ki (nM),11,PMID:19147350|DOI:10.1016/j.bmcl.2008.12.092,https://www.ncbi.nlm.nih.gov/pubmed/19147350|https://doi.org/10.1016/j.bmcl.2008.12.092,19147350,10.1016/j.bmcl.2008.12.092,
521,2055133,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5834,PYGB,https://ctdbase.org/detail.go?type=gene&acc=5834,,,5834.0,PYGB,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PYGB protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
522,2055134,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5860,QDPR,https://ctdbase.org/detail.go?type=gene&acc=5860,,,5860.0,QDPR,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of QDPR protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
523,2055135,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,9444,QKI,https://ctdbase.org/detail.go?type=gene&acc=9444,,,9444.0,QKI,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of QKI protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
524,2055136,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,23475,QPRT,https://ctdbase.org/detail.go?type=gene&acc=23475,,,23475.0,QPRT,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of QPRT protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
525,2055137,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,51552,RAB14,https://ctdbase.org/detail.go?type=gene&acc=51552,,,51552.0,RAB14,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB14 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
526,2055138,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5862,RAB2A,https://ctdbase.org/detail.go?type=gene&acc=5862,,,5862.0,RAB2A,9606,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB2A protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
